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8General introductionChapter 1
There is an increasing group of older people with intellectual disability in The Netherlands. 
Intellectual disability is defined as significant limitations both in intellectual functioning 
(an IQ lower than 70) and problems in adaptive behavior, which cover a range of everyday 
social and practical skills, and occur before the age of eighteen [1]. In the Netherlands 
approximately 160,000 people with intellectual disability receive special education or 
any other form of support [2]. The population with intellectual disability is increasingly 
growing older, reaching almost the same life expectancy as the general population, which 
means that there are over 30,000 people with ID aged 50 years and over, making use of 
some form of specialized care services. Currently most people with intellectual disability 
live in the general community. This means that half of all people aged 50 years and over 
live in the community, for example in group homes or with ambulatory support, making 
use of standard general and secondary health services. The other half lives in a setting with 
more specialized care, receiving specialist medical care by ID physicians [3]. Moreover, it 
is estimated that there are over 1.1 million people with borderline intellectual disability 
(IQ 70–85) in The Netherlands [4], who do not all have access to specialized care or 
support services and grow older, too.
This increasing group of aging people more and more faces the same health problems 
as the general older population. Due to improved knowledge and care on the disability-
specific health challenges (syndromes with specific morbidity, epilepsy, recurrent 
pneumonia due to reflux and aspiration) such issues no longer are a main cause of 
early mortality. The normal age-related diseases, such as cardiovascular disease, cancer 
and dementia are now the most encountered diseases in older people with intellectual 
disabilities. In the general population there is a lot of attention and research into the 
occurrence of these diseases, which is the basis for prevention, but also for early treatment. 
This attention lacks in the intellectually disabled population. Until the Healthy Aging and 
Intellectual Disability study was started, no large preventive studies had been published or 
preventive health campaigns undertaken. This might be due to the fact that large studies 
in this population are difficult to perform. But in general, cardiovascular disease risks 
have received too little attention. Moreover there was a lack of preventive attitude in the 
care for people with intellectual disabilities. This means that without interventions, the 
burden of cardiovascular disease and cardiovascular mortality can increase in older people 
with intellectual disability, in contrast to the decreasing trend in the general population. 
Cardiovascular disease, such as myocardial infarction or stroke, in addition to the existent 
intellectual and possibly physical disabilities, will worsen disabilities and make people 
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more dependent on others in daily activities and in care. This decreases quality of life 
and increases health care costs for this population.
First of all, the health care problem needs to be mapped. How big is the problem we are 
facing? Then, targeted interventions can be designed, to improve knowledge in daily practice 
and thus change health-related behavior (lifestyle). This includes education of personal 
care-givers and people with intellectual disabilities themselves. Scientific knowledge can be 
improved, to unravel which mechanisms of disease are of particular interest in this specific 
population. Then evidence based interventions can be designed, that should not only be 
started, but also continued in order to result in significant health improvement.
The Healthy Aging and Intellectual Disability study
To gain more knowledge on the health and aging aspects of the growing population of 
older people with ID, the Healthy Aging and Intellectual Disability (HA-ID) study was 
initiated [5]. This study was explicitly designed to focus on preventive health care. Three 
large care organizations and two university departments participated in this study. The 
care organizations offer low to high level specialized support and care to people with 
intellectual disability. This is a unique collaboration between these organizations and 
the university, with the aims to improve scientific knowledge, advance expertise of 
professional staff, and develop evidence-based interventions for daily practice. Research 
themes were chosen based on actual questions from clients and professional staff, but 
also based on current epidemiologic research trends in the general older population [6, 
7]. Subthemes in the HA-ID study were: (1) Physical activity and fitness, (2) Nutrition 
and nutritional state, and (3) Mood and anxiety. By studying these themes and the 
interrelationships, a comprehensive concept of health and health-needs in aging people 
with intellectual disability would be created. Through physical examination, laboratory 
examination, and use of screening and diagnostic psychiatric interviews, data were 
collected on 1050 participants, which was a near-representative sample for the total older 
population using formal intellectual disability care [5].
Cardiovascular risk factors
Atherosclerotic cardiovascular diseases are a major cause of death in the older general 
population. In older people with intellectual disability, international research into 
cardiovascular morbidity was scarce. Only two Dutch studies indicated that cardiovascular 
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events occurred at least as frequently as in the general population, but underdiagnosis 
was suggested [8, 9]. Cardiovascular diseases are caused by cardiovascular risk factors, 
such as obesity, hypertension, diabetes, hypercholesterolemia (a combination of these 
factors is defined as the metabolic syndrome), smoking, physical inactivity and also a 
genetic predisposition.
Research into cardiovascular risk factors was practically limited to research into obesity. 
It had been shown that obesity was an increasing problem in adults with intellectual 
disability [10-16]. In population-based studies, the prevalence of obesity (by Body Mass 
Index (BMI)) was significantly higher than in the general population [17-19]. Obesity 
in older people with intellectual disability was less often studied and only in smaller or 
biased samples [20, 21]. Although it was well established that waist-to-hip ratio and, to a 
somewhat lesser extent, the waist circumference were much stronger indicators for risk 
on myocardial infarction than BMI[22], all larger studies only investigated BMI outcomes 
[15-18]. Body fat percentage would provide more information on nutritional state than 
weight data only, but this had not been studied on a large scale in adults with intellectual 
disability [10], and had never been studied in older people with intellectual disability. 
Other cardiovascular risk factors (diabetes, hypertension and hypercholesterolemia) 
had been insufficiently investigated in older people with intellectual disability. Until 
the start of the HA-ID study, earlier studies had only been performed in small or biased 
populations [20, 21, 23-25], or were based on questionnaires [26-28] and results had 
been inconclusive. Cardiovascular risk factors were reported to occur less frequently [26, 
29], similar [21, 23, 24, 30] or more frequently [21, 25] than in the general population.
Since cardiovascular risk factors are, apart from the genetic predisposition, lifestyle-
related, people with an unhealthy diet and a sedentary lifestyle are more at risk. Physical 
inactivity is a widespread problem among people with intellectual disability [31, 32]. 
Physical inactivity is a well-known risk for developing obesity. But also the larger muscles 
metabolize body glucose, and thereby contribute to the development of diabetes when 
muscles are inactive for long periods during the day [33]. There are indications that people 
with mild or borderline intellectual disability and those who live relatively independent 
are more at risk of obesity than people with more severe levels of intellectual disability 
[17-19, 34], which suggested that these people made more unhealthy choices regarding 
their lifestyle (diet) as they might not be able to oversee long-term consequences. Another 
important causal factor in cardiovascular risk factors is the widespread use of antipsychotic 
medication [35, 36]. These agents are often prescribed off-label, usually for behavioral 
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problems, such as aggression or self-injurious behavior [35], but effectivity on these 
indications has not been proven [37]. Especially atypical antipsychotic drugs have the well-
known side-effect of weight gain and development of the metabolic syndrome [38-40].
Atherosclerosis
The presence of cardiovascular risk factors leads to the development of atherosclerosis. 
This may first appear in the smaller peripheral vessels. Peripheral arterial disease 
(atherosclerosis distal from the aortic bifurcation) is a vascular disease, which can 
lead to pain in the lower limbs while walking. But it is also an indicator of generalized 
atherosclerosis [41] and an increased risk of larger cardiovascular events (such as 
myocardial infarction and cerebrovascular accidents) and mortality [41-43]. There was 
no information on the prevalence of (peripheral) atherosclerosis in older people with 
intellectual disability.
Comorbid conditions
Cardiovascular risk factors are bidirectionally related to depression and anxiety [44-47]. 
Underlying mechanisms are that depression and anxiety cause hormonal effects, resulting 
in abdominal fat accumulation, impaired glucose tolerance and high blood pressure 
[44, 46, 47]. Moreover, people with anxiety and depression tend to have poor health 
behavior (e.g. unhealthy diet, smoking, sleep disturbance and low physical activity) [44, 
47]. In the opposite direction, depression and anxiety may be caused by increased levels 
of inflammatory proteins, released from atherosclerotic plaques in the blood vessels, as 
well as impaired glucose homeostasis and cerebral vascular damage [44, 47]. Further, 
obesity, diabetes, cardiovascular disease and the subsequent necessary lifestyle changes 
may result in low self-esteem and fear [44, 46, 47].
As part of the cardiovascular risk management, kidney functioning should be monitored, 
as kidney functioning is decreased by hypertension, diabetes and atherosclerosis. In this 
way, kidney disease may advance cardiovascular morbidity and mortality. Only one limited 
study on kidney functioning in adolescents with intellectual disability was available [48], 
suggesting that chronic kidney disease was a significant health problem, but no studies 
were available in adults and older people with intellectual disability.
Chap1_Channa.indd   11 9-7-2014   9:29:36
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Study aims
This study was performed to give more insight into the prevalence and associations of 
cardiovascular risk factors, and the subsequent development of atherosclerosis, in older 
people with intellectual disability in a large unbiased population sample.
The first cardiovascular disease risk factor, obesity, will be described in chapter 2. Using 
multiple measures of anthropometry, an overview will be provided of the full scope of this 
health issue. In addition to BMI measurement information on body composition, based on 
skin fold measurement to calculate body fat percentage will also be provided. Moreover, 
a broad range of associated client characteristics, such as gender, age, independent living 
and use of atypical antipsychotics will be presented.
The other cardiovascular risk factors, hypertension, diabetes, hypercholesterolemia and 
the metabolic syndrome, will be described in chapter 3. Prevalence will be described, 
indicating not only a burden of disease due to these conditions, but also a risk on 
subsequent cardiovascular disease. Associated factors will be described, indicating which 
subgroups may be particularly at risk.
The consequences of the cardiovascular risk profiles as described in chapter 2 and 3, 
the development of atherosclerosis, will be reported in chapter 4. In this chapter, results 
on prevalence and associated factors of peripheral arterial disease, as measured by the 
ankle-brachial index will be presented. As this is also an indication for the occurrence of 
larger cardiovascular events this also contributes to the total cardiovascular risk profile.
Studying the interrelationships of subthemes (in this case nutritional state and mood 
disorders) was one of the main goals of the HA-ID study, providing a comprehensive view 
on mechanisms and comorbidity. The bidirectional relationship of the cardiovascular 
risk factors and atherosclerosis and depression and anxiety will be described in chapter 5.
As no cardiovascular risk management is complete without screening for possible kidney 
damage, in chapter 6 chronic kidney disease will be studied, as an associated factor of 
cardiovascular risk factors and atherosclerosis.
The general discussion (chapter 7) reflects on the findings in this thesis and provides 
recommendations for clinical practice and future research.
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ABSTRACT
Overweight and obesity are major health problems associated with increased 
cardiovascular disease risk, which is not sufficiently studied in people with 
intellectual disability yet. The present study was part of the Healthy Aging in 
Intellectual Disability (HA-ID) study. The aim of this study was to establish (1) 
the prevalence of overweight, obesity and body fat percentage in older people with 
intellectual disability (ID) through measurement of Body Mass Index (BMI), waist 
circumference, waist to hip ratio (WHR) and skin fold thickness, and compare this 
with prevalence of overweight and obesity in the general population, and (2) the 
association of overweight and obesity with participant and treatment characteristics 
(gender, age, level of ID, Down syndrome, autism, independent living, smoking, 
(instrumental) activities of daily living ((I)ADL), physical activity and use of atypical 
antipsychotic medication) using regression analyses. In this cross-sectional study 
945 persons, aged 50 and over with borderline to profound ID, living in central 
settings, in community settings and independently were included. Overweight and 
obesity were highly prevalent, with more obesity (26%) than in the general Dutch 
older population (10%) as measured by BMI, and 46-48% obesity as measured by 
waist circumference and WHR respectively. Women, people with Down syndrome, 
higher age, less severe ID, autism, people who are able to eat independently, preparing 
meals and doing groceries independently, people with physical inactivity and use of 
atypical antipsychotics were significantly more at risk of being overweight or obese. 
This merits specific actions by policy makers and clinical practice to improve health 
outcomes.
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2.1 InTRoduCTIon 
Overweight and obesity are major health problems worldwide. They are generally known 
to cause cardiovascular disease and are the third risk factor for causes of death in middle 
and high income countries [49]. It has been shown that obesity is an increasing problem in 
adults with intellectual disability (ID) [10-16]. In population based studies in this group, 
the prevalence of obesity (by Body Mass Index (BMI)) ranges from 21 to 35%, which is 
significantly higher than in the general population [17-19]. Within the ID population, 
people with Down syndrome [50-52], women, people with mild ID and people who live 
independently [17-19, 34] are more at risk of being overweight or obese. 
With increasing longevity in people with ID, obesity can be expected to become a major 
problem in older people with ID as well. However data on this group are scarce, and 
only available from small or biased samples. In a retrospective chart study among 155 
Australians aged 40-74 who visited a specialized clinic for ageing people with ID, 85 
patients had their weight checked. 70% were overweight or obese [20]. In a cross-sectional 
study among 470 Dutch people with ID, aged 50-90, 24.7% of the respondents was 
centrally overweight and 45.7% had central obesity as measured by waist circumference, 
whereas 15% had obesity as measured by BMI. This sample was biased, because women 
and people with moderate and severe ID were overrepresented [21].
Although it is well established that waist-to-hip ratio (WHR) and, to a somewhat lesser 
extent, the waist circumference are much stronger indicators for risk on myocardial 
infarction than BMI [22], all large studies investigated BMI outcomes [15-18]. Body fat 
percentage would provide more information on nutritional state than weight data only 
(how is the body composed, and what are the consequences, for example, if there is loss of 
muscle mass due to obesity, which would give an increased body fat percentage), but this 
has not been studied on a large scale in adults with ID [10], and has never been studied 
in older people with ID. Knowledge on cardiovascular morbidity risk and nutritional 
state in this population is thus incomplete.
Studying related factors will provide insight into risk factors of obesity and information 
needed for the design of interventions. Apart from already identified determinants we 
studied the following potential determinants. Since level of ID and activities of daily 
living (ADL) and instrumental activities of daily living (IADL) are related [53], it can be 
expected that high ADL and IADL scores are also correlated with obesity. Furthermore, 
we expected that lower levels of physical activity would predict obesity [32]. Adolescents 
Chap2_Channa.indd   17 9-7-2014   9:29:58
18
Overweight and obesity Chapter 2
with autism and ID have a higher prevalence of obesity than adolescents with other 
types of disabilities [54]. There may also be high levels of obesity in older people with ID 
and autism. Finally it is well known that people with ID tend to be overmedicated with 
antipsychotic drugs [35]. The metabolic consequences of the use of atypical antipsychotic 
medication are well established, including weight gain [55]. Thus we hypothesized that 
the use of atypical antipsychotics is one of the determinants of obesity in older people 
with ID.
The aim of the present study is to provide information on overweight and obesity in a 
large sample of older adults with ID, investigating:
1. the prevalence of overweight, obesity and body fat percentage through measurement 
of BMI, waist circumference, WHR and skinfold thickness, and compare this with 
prevalence of overweight and obesity in the general population.
2. the association of overweight and obesity with participant and treatment characteristics 
(gender, age, level of ID, Down syndrome, autism, independent living, smoking, ADL, 
IADL, physical activity and use of atypical antipsychotic medication).
2.2 MeThodS 
2.2.1 design
This study is part of a large cross-sectional study, titled ‘Healthy Ageing and Intellectual 
Disability’ (HA-ID) [5]. Three care-providing organizations in the Netherlands 
participated in the study. These organizations offer low to high level specialized support 
and care to people with ID. Subthemes in this study are: (1) Physical activity and fitness, 
(2) Nutrition and nutritional state, and (3) Mood and anxiety [5]. Assessing overweight, 
obesity and body composition is part of the subtheme concerning nutrition and nutritional 
state. Ethical clearance has been provided by the Medical Ethics Committee of the 
Erasmus Medical Center Rotterdam (MEC 2008-234) and by the ethics committees of 
the participating care providing organizations. The study adheres to the Declaration of 
Helsinki for research involving human subjects [56].
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2.2.2 Participants
A full description of details about design, recruitment and representativeness of the sample, 
as well as diagnostic methods, has been published elsewhere [5]. All 2150 clients of the three 
participating organizations, aged 50 years and over, were invited to participate. Informed 
consent was provided by 1069 clients or their legal representatives, of whom 1050 clients 
participated in the assessments. This study population was almost representative for the 
total Dutch older ID population receiving formal care or support. Only people living 
independently and people aged 80 years and over were slightly underrepresented [5]. 
2.2.3 data collection
Gender and age were collected from the records of the care providers. Participant 
characteristics were obtained from medical files and files of the behavioural therapists. 
General practitioners and specialized ID physicians recorded etiology (Down syndrome 
yes/no) and use of atypical antipsychotic medication (olanzapine, risperidone and 
quetiapine). Psychologists or behavioural therapists recorded level of ID and diagnosis 
of autism.
Participants underwent physical examination to assess indicators of overweight and 
obesity and body composition by specially trained medical assistants. When people 
showed any kind of (unusual) resistance, measurements were immediately stopped 
and people were considered as non-participants. Body height was measured using a 
Seca stadiometer, type 214, with the participant standing, wearing no shoes. For non-
ambulant people, knee height was measured using a non-stretchable flexible tape, and 
Chumlea’s formula was used to calculate body height [57]. Weight was measured using 
a digital floor scale (Seca robusta type 813), with participants wearing light clothes and 
no shoes. BMI was calculated by weight divided by squared height [58]. BMI ≥25 kg/m² 
was classified as overweight and ≥30 kg/m² as obese. Using non-stretchable standard 
tapes, waist circumference was measured over the unclothed abdomen at the narrowest 
point between the costal margin and iliac crest, and hip circumference was measured 
over light clothing at the level of the widest diameter around the buttocks. For men waist 
circumference ≥94 cm was classified as overweight and ≥102 cm as obese. For women, 
waist circumference ≥80 cm was classified as overweight and ≥88 cm as obese. Waist-
to-hip ratio (WHR) ≥0.90 was classified as overweight and ≥1.00 as obese for men, and 
WHR ≥0.80 was classified as overweight and ≥0.88 as obese for women [58]. Thickness of 
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skinfolds was measured with a skinfold caliper (Harpenden). The sum of four skinfolds: 
triceps, biceps, subscapular and suprailiacal, was used to calculate body density using the 
Visser equation [59]. The Visser equation has been validated in a Dutch group of older 
adults. Body fat percentage was calculated from body density using Siri’s equation [60].
Physical activity was assessed by wearing pedometers for two weeks [32]. We classified a 
minimum of 7500 steps/day as sufficient physical activity [32]. Professional care-givers 
were asked about smoking (minimum 1/day), activities of daily living (ADL) by Barthel 
index [61] and Instrumental Activities of Daily Living by Lawton and Brody [53, 62].
Comparable data from the general Dutch population were only found for BMI. Statistics 
Netherlands interviewed 10,000 Dutch adults by telephone in 2009 and published age 
and gender specific results [63].
2.2.4 Statistical analysis
Data were analyzed using IBM SPSS Statistics 17.0. Descriptive statistics are provided. 
With chi-square analysis we explored if there are any differences between the participants 
of the abovementioned assessments and the total HA-ID study population in gender, age 
(age groups 50-59, 60-69, 70-79, 80+), level of ID (borderline, mild, moderate, severe, 
profound) and independent living (central setting, community based or independent 
with ambulatory support, with relatives).
To explore associations between weight data (BMI, waist circumference, WHR and body 
fat percentage) (dependent variables) and participant characteristics; gender (n=945), 
age(n=945), level of ID (n=924), diagnosis of Down syndrome (n=830), diagnosis of 
autism (n=888), smoking (n=899), independent living (n=945), ADL items and total score 
(n=905), IADL items and total score (n=905), physical activity (n=253), use of atypical 
antipsychotics (n=837) (independent variables), univariate logistic regression (BMI, waist 
circumference and WHR) and univariate linear regression (body composition) analyses 
were performed. If an independent variable showed a significant association (p<0.05) 
with the dependent variable, it was subsequently entered into a multivariate regression 
analysis. Items of ADL and IADL were all entered separately in the univariate analyses. 
From ADL and IADL the separate item or total score that correlated strongest was entered 
in the multivariate model (to prevent multicollinearity).
For BMI, multinomial regression analysis was used to compare groups with normal BMI, 
overweight and obesity. For waist circumference and WHR, binomial logistic regression 
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analyses were used for people with obesity versus people with normal weight and/or 
overweight, because of the small amount of people in the normal weight group.
Because no generally accepted reference values exist for the amount of body fat, body fat 
percentage was used as a linear measure. Therefore, multivariate linear regression was 
performed to study associations.
Independent variables were entered into the multivariate regression equation 
simultaneously. Independent variables were checked for multicollinearity, using Pearson’s 
correlation coefficient. If a reasonably high correlation existed (>.400), we entered the 
variables separately in the models, to see if any change in associations with the dependent 
variable or explaining value of the model occurred. If this happened, we would provide 
both models in the results section. For linear regression two measures for multicollinearity 
are provided. A Variance Inflation Factor (VIF) of 10 or higher is reason for concern 
(Myers, 1990), and Tolerance values should be 0.2 or higher. 
People with missing data on BMI, waist circumference, WHR or body fat percentage 
were excluded from analysis in that particular model.
2.3 ReSuLTS
2.3.1 Study population
Of the 1050 participants in the total cohort, 945 participated in the physical examination. 
Mean age was 61.5 years (range 50-93). Characteristics of the study population are 
shown in Table 2.1. Representativeness of the groups of participants are shown in Table 
2.2. People with profound ID, living in central settings were underrepresented, whereas 
people with mild ID, living in community settings were slightly overrepresented. This 
reflects resistance to physical assessments. Moreover, the smallest age group, people aged 
80 and over, were underrepresented in the assessment of BMI and waist circumference, 
and men were overrepresented in measurement of body fat percentage.
2.3.2 Prevalence of overweight and obesity
Prevalence of overweight and obesity by BMI, waist circumference and waist-to-hip 
ratio (WHR) are presented in Table 2.2. Mean body fat percentage (n=664) was 37.6% 
(95% confidence interval (CI) 37.0-38.1%, SD 7.1), 31.6% (95% CI 31.3-31.9%, SD 
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Table 2.1 Characteristics of the study population (n=945)
N %
Gender
Male 482 51.0
Female 463 49.0
Level of ID
Borderline 30 3.2
Mild 204 21.6
Moderate 454 48.0
Severe 151 16.0
Profound 84 8.9
Unknown 7 0.7
Down syndrome 132 14.0
Autism 149 15.8
Table 2.2 Representativeness of the study population as compared to the Total HA-ID popu-
lation
BMI Waist circumference WHR Body fat percentage
Gender ns ns ns + (men)
Central setting - - - -
Community setting + + + +
Independent living ns ns + ns
Age 50-59 ns ns + ns
Age 60-69 ns ns ns ns
Age 70-79 ns ns - ns
Age 80+ - - ns ns
Borderline ID ns ns + ns
Mild ID ns ns + +
Moderate ID ns ns ns ns
Severe ID ns ns ns -
Profound ID - - - -
ns = non significant difference between study population and HA-ID population; - = underrepresented; 
+ = overrepresented.
2.9) in men and 44.7% (95% CI 44.4-45.0%, SD 2.9) in women. Comparison with the 
prevalence of overweight and obesity by BMI in the general population is shown in 
Table 2.3.
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2.3.3 Associations of overweight and obesity
2.3.3.1 Associations with BMI
Results of univariate analyses are shown in Table 2.4. Searching for multicollinearity 
resulted in significant correlations between level of ID, being able to eat independently 
(ADL) and being able to do groceries independently (IADL) with p<0.001 and Pearson’s 
correlations between these variables were all 0.40-0.50. Thus the variables were first 
entered simultaneously in the analysis and subsequently the model was repeated with 
each time only one of these three variables. The whole model is shown in Table 2.4, with 
the results for these three measures entered separately. The proportion explained variance 
of the model did not increase and statistical significance and ORs of the other variables 
did not change significantly with this intervention.
Table 2.3 Prevalence of overweight and obesity by BMI, waist circumference and waist-to-
hip ratio in study population and comparison with BMI from general Dutch population (aged 
45+) (Statistics Netherlands 2011)
ID population General population
Overweight% 
(95% CI)
Obese% 
(95% CI)
Overweight% 
(95% CI)
Obese% 
(95% CI)
BMI
Male (n=454) 39.2 
(34.7-43.7)
13.7 
(10.5-16.8)
Male (n=1873) 47.7 
(45.5-50.0)*
13.2 
(11.6-14.7)
Female (n=439) 37.1 
(32.6-41.7)
38.0 
(33.5-42.6)
Female (n=1790) 35.3 
(33.0-37.5)
14.8 
(13.2-16.5)*
Total (n=893) 38.2 
(35.0-41.4)
25.6 
(22.8-28.5)
Total (n=3663) 41.2 
(39.6-42.8)
9.6 
(8.7-10.6)*
Waist
Male (n=461) 23.9 
(20.0-27.8)
26.7 
(22.6-30.7)
Female (n=437) 19.0 
(15.3-22.7)
66.4 
(61.9-70.8)
Total (n=898) 21.5 
(18.8-24.2)
46.0 
(42.7-49.3)
Waist-hip ratio
Male (n=418) 51.0 
(46.2-55.8)
33.3 
(28.7-37.8)
Female (n=416) 22.4 
(18.4-26.4)
63.0 
(58.3-67.6)
Total (n=834) 36.7 
(33.4-40.0)
48.0 
(44.7-51.5)
* Confidence intervals do not overlap between ID population and general population.
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Being female was a higher risk for both being overweight or obese vs normal weight, but 
also for being obese vs overweight. Increasing age was a higher risk for being overweight. 
Having a diagnosis of autism was associated with obesity. Use of atypical antipsychotics 
was associated with more obesity versus overweight. A less severe ID, being able to 
eat independently and being able to do groceries independently were all significantly 
correlated with overweight and obesity and also caused a higher risk for obesity compared 
to being overweight. The proportion explained variance (R²) of the model was .21.
2.3.3.2 Associations with waist circumference
For waist circumference binomial (multivariate) logistic regression analysis was 
performed to find associations with the obesity group, compared to the normal/
overweight group. Independent variables included in the model were gender, age, level 
of ID, Down syndrome, having a diagnosis of autism, (semi-) independent living, being 
able to eat independently (ADL), being able to do groceries independently (IADL) and 
physical activity<7500 steps/day. Possible multicollinearity existed between level of ID, 
independent living, being able to eat independently (ADL) and being able to do groceries 
independently (IADL). These variables were subsequently entered in separate models, 
together with gender, age, Down syndrome, having a diagnosis of autism and physical 
activity<7500 steps/day. The whole model is shown in Table 2.4 with the results for these 
four measures entered separately in the analysis. The proportion explained variance of 
the model (Table 2.4) did not increase and significance and ORs of the other variables 
did not change significantly with this intervention.
Women, people with Down syndrome, people who were physically inactive (<7500 steps/
day) and people who were able to do groceries independently had significantly more obesity 
by waist circumference. The proportion explained variance (R²) of the model was .33.
2.3.3.3 Associations of waist to hip ratio
For WHR, binomial (multivariate) logistic regression analysis was performed to 
investigate associations with the obesity group as compared to the normal/overweight 
group. Independent variables entered in the model were gender, age, Down syndrome, 
being able to eat independently (ADL), being able to prepare a meal independently 
(IADL). Multicollinearity was not a problem in this model. Women, people with higher 
age, people with Down syndrome, people who were able to eat and/or prepare a meal 
independently were significantly more at risk of being obese by WHR (Table 2.4). The 
proportion explained variance (R²) of the model was .25.
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2.3.3.4 Associations of body fat percentage
For body fat percentage, linear regression analysis was performed. Independent variables 
included in the model were gender, level of ID, Down syndrome, being able to eat 
independently (ADL), total score on IADL and physical activity<7500 steps/day. Based 
on Tolerance and VIF values, multicollinearity was not a problem in this model. Women 
and people who were physically inactive had a significantly higher body fat percentage 
(Table 2.4). The proportion explained variance (R²) of the model was .78.
2.4 dISCuSSIon
This is the first study applying multiple measures of overweight and obesity in a large 
sample of older adults with ID. Overweight and obesity are highly present within this 
group: 38% are overweight and 26% obese according to body mass index (BMI), whereas 
with waist circumference and waist-to-hip ratio (WHR), proportions of obesity are even 
higher, with 22-37% being overweight and 46-48% being obese, respectively. Compared to 
the general Dutch population aged 45+ [63] using BMI, prevalence of being overweight 
is similar, whereas obesity is more prevalent in people with ID (Table 2.2). Looking more 
closely, our results show that men with ID are less overweight, but similarly obese, whereas 
women with ID suffer more often from obesity, but no differences were observed for being 
overweight. For waist circumference, WHR and body fat percentage, no comparable data 
from the general Dutch population were available. Prevalence of obesity, as measured 
with waist circumference and WHR, were higher than prevalence of overweight. This 
was not found with BMI. As in the general population, women, people with higher age, 
and people with insufficient physical activity are more at risk for being overweight or 
obese [64]. ID-population specific risk groups are people with Down syndrome, people 
using atypical antipsychotics, people with autism, less severe ID and people who can eat 
independently and do groceries and prepare a meal independently.
With studying related factors of obesity in older people with ID explained variance was 
not very high for BMI (R²=.21), waist circumference (R²=.33) and WHR (R²=.25). This 
means that obesity and overweight are also present in other subgroups than the above-
mentioned risk groups, and that other factors (for example diet composition or genetic 
syndrome related factors), not yet identified in this study, may also account for obesity 
in this group. The explained variance of the body fat percentage model was very high 
(R²=.78), which means that gender and physical inactivity account for a large part of the 
risk on a high body fat percentage.
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A limitation of the present study was that we compared our data to published data of 
the general population and that these were not available for waist circumference, WHR 
and body fat percentage. A further limitation is that no validated reference values for 
overweight and obesity are available for body fat percentage [65], and that body fat 
percentage had to be computed from skin fold measurement, because the gold standard 
(DEXA-measurement or densitometry) is not feasible in large scale epidemiologic 
research in people with ID. For computing body fat percentage, Visser’s equation was 
used based on four skinfold measurements [59]. This equation was developed and 
validated for the older Dutch population in 1994. We hypothesized that, although in 
general (as a time trend), people may have become more often overweight or obese, and 
thus mean body fat percentage has increased, the relation between skinfold thickness 
and body fat percentage did not change significantly over time. Furthermore, a recent 
study showed that Visser’s equation is still valid in the general older population [66]. With 
measurement of body fat percentage, selection bias occurred due to overrepresentation 
of men (which will result in an underestimation of the mean body fat percentage in the 
total group), which is why it is best to look at gender-specific numbers. Furthermore 
people with mild ID were overrepresented and people with severe and profound ID were 
underrepresented, and people living in community based settings were underrepresented. 
As people with borderline ID and living independently were equally represented in the 
sample we conclude that skinfold measurement is possible in people with ID but can 
result in more resistance in people with more severe levels of ID. Since age, level of ID 
and independent living were not significantly correlated with body fat percentage this 
did not influence mean levels of body fat percentage. For the measurement of BMI, waist 
circumference and WHR, people with profound ID who were living in central settings 
were underrepresented, whereas people with mild ID and living in community settings 
were overrepresented. This reflects resistance to the physical examination, and may give 
an overestimation of the prevalence of overweight and obesity by these measures, as 
people with more independent functioning are more at risk.
A strength of this study was, apart from the large sample, that overweight and obesity were 
studied with multiple measures, fully capturing all aspects of obesity, including the best 
predictors for ischaemic heart disease (waist circumference and WHR) [22]. This makes 
our outcomes a valuable indication of an increased morbidity risk. Another strength was 
the large set of correlates studied, including both (ID specific) physical circumstances, 
and behavioural and lifestyle related factors were included. These correlates were studied 
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much more objectively (such as physical activity and ADL and IADL), than in a previous 
study in older people with ID [21].
Possible explanations for the high prevalence of overweight and obesity are, that older 
people with ID cannot oversee long-term effects of eating unhealthy food. Since people 
who are able to do groceries, prepare meals and eat by themselves are more at risk, they 
may not have sufficient knowledge on what is healthy and what is not, and how to prepare 
healthy meals. Furthermore, people may have small budgets and unhealthy meals tend to 
be cheaper. People with autism were more at risk of obesity. This has also been reported 
in adolescents [54] and may thereby be a problem since young age.
Especially the high levels of obesity as measured by waist circumference and WHR, 
which represent central obesity and are strongly correlated to cardiovascular disease [22], 
warrant concern. To treat obesity in older people with ID, especially in people with more 
independent functioning, education on healthy behavior is urgently needed. Knowledge 
and intake of healthy food should be promoted. Encouraging physical activity is very 
important, both to lose weight and to prevent cardiovascular disease. Older people with 
ID need active support in changing these behaviors and maintaining a healthy lifestyle. 
Furthermore, doctors should be cautious with prescribing (atypical) antipsychotics, which 
are frequently used off-label in people ID and have severe metabolic side-effects [35].
The results of the present study give rise to additional research questions: Is the high rate 
of central obesity by waist circumference and WHR an ID-population specific problem, 
or is this a problem in the general population as well? And does this reflect only high 
amounts of abdominal fat, or is there also loss of muscle mass (increased fat sarcopenia), 
specific for this group? Therefore we would also need to know the body fat percentage 
in the general population. Are older people with ID more vulnerable to obesity and 
subsequent cardiovascular disease than the general older population? These questions 
need to be answered prospectively.
In conclusion, using multiple measures to assess overweight and obesity in older adults 
with ID reveals a huge problem in this population. High prevalence rates of overweight 
and obesity not only influence individual health in older adults with ID, but increase the 
risk of cardiovascular conditions, and practice as well as policy should be aware of these 
avoidable consequences for health care costs and quality of life.
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ABSTRACT
Hypertension, diabetes, hypercholesterolemia and the metabolic syndrome are 
important risk factors for cardiovascular disease (CVD). In older people with 
intellectual disability (ID), CVD is a substantial morbidity risk. The aims of the 
present study, which was part of the Healthy Aging in Intellectual Disability (HA-ID) 
study, were (1) to determine the prevalence of CVD risk factors in older people with 
ID and to compare this with the prevalence in the same-aged general population, 
(2) to determine how many risk factors had not been previously diagnosed, and (3) 
to identify correlates of CVD risk factors (gender, age, level of ID, Down syndrome, 
independent living, activities of daily living, mobility, instrumental activities of 
daily living, physical activity, use of atypical antipsychotics, central obesity), using 
logistic regression analyses. In this cross-sectional study, 980 people with borderline 
to profound ID participated. Hypertension (53%), diabetes (14%) and metabolic 
syndrome (45%) were present similarly as in the general Dutch population. 
Hypercholesterolemia was present less often (23%). Fifty percent of the people with 
hypertension had not been not previously diagnosed with this condition. Percentages 
for diabetes, hypercholesterolemia, and the metabolic syndrome were 45, 46 and 94 
respectively. People who were more at risk for CVD risk factors were women, older 
people, people with obesity, people who lived more independently and people who 
were able to do groceries or prepare a meal independently. Policy on prevention, 
detection and treatment of CVD risk factors is urgently needed.
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3.1 InTRoduCTIon 
Hypertension, hypercholesterolemia and diabetes mellitus are directly related to 
cardiovascular disease (CVD), and are major risk factors for causes of death not only in 
high income countries, but worldwide [49]. The metabolic syndrome, a complex of these 
risk factors and abdominal overweight with insulin resistance as a possible underlying 
mechanism, leads to CVD [67].
Cardiovascular disease can also be expected to become a major burden of disease and 
cause of death in older people with intellectual disability (ID), because of increasing 
longevity, as well as a high prevalence of obesity [68] and a sedentary lifestyle [28, 31, 
32]. Moreover, cardiovascular disease is associated with certain genetic syndromes 
(such as Bardet-Biedl syndrome [69], Prader-Willi syndrome [70], sex-chromosomal 
abnormalities, Werner’s syndrome, as well as mitochondrial defects and congenital rubella 
syndrome[71]). Evidence on CVD in people with ID is scarce. In two studies, combined 
prevalence of coronary artery disease and cerebrovascular accidents in older people with 
ID was 3.2% [8] and 5.7% [9], which was not different from prevalence in the general 
population. However, more cerebrovascular accidents were reported than myocardial 
infarctions[9]. This indicates that the latter diagnosis might be missed, because people 
with ID may be less able to communicate pain or other signs of myocardial infarction, 
leading to an under estimation of the prevalence [9].
CVD risk factors (diabetes, hypertension and hypercholesterolemia) have been 
insufficiently investigated in older people with ID. Until now, studies have only been 
performed in small or biased populations [20, 21, 23-25], or were based on questionnaires 
[26-28] and results have been inconclusive. CVD risk factors were reported to occur less 
frequent [26, 29], similar [21, 23, 24, 30] or more frequent [21, 25] than in the general 
population. We have studied overweight and obesity as part of the HA-ID study and 
found a higher prevalence of obesity by body mass index than in the general population. 
Moreover, similar to the general population there were very high rates of abdominal 
obesity, which gives an increased risk of CVD [68].
 Several subgroups have been reported to have more CVD risk factors. People with a less 
severe ID [21, 25], more independent living and functioning [68] and less physical activity 
[72] are more at risk. Moreover, there is a widespread use of (atypical) antipsychotics 
[35], which is associated with metabolic changes [73]. Smoking is associated with CVD 
risk factors [74, 75], but this association has not been investigated in older people with 
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ID. However, smoking is an increasing problem among people with ID [16]. In contrast, 
people with Down syndrome are suggested to be less at risk for CVD risk factors [76].
Underdiagnosis of CVD risk factors has been suggested to be an important pitfall [26, 77]. 
To justify an active CVD prevention policy, it is necessary to determine the prevalence 
of CVD risks in older people with ID. We hypothesize that many risk factors remain 
undiagnosed in this group, which would require an active approach for detecting these 
risk factors. Studying related factors aids in focusing on groups that are more at risk and 
making strategies to promote health in these specific groups. Therefore the aims of the 
present study were:
1. To determine the prevalence of hypertension, diabetes mellitus, hypercholesterolemia 
and metabolic syndrome in older people with ID, using formal ID services, and to 
compare this with the prevalence in the general older Dutch population.
2. To determine how many new diagnoses of CVD risk factors are found.
3. To identify correlates of cardiovascular risk factors (gender, age, smoking, level of ID, 
Down syndrome, residential setting, activities of daily living, mobility, instrumental 
activities of daily living, physical activity, use of atypical antipsychotics, central 
obesity).
3.2 MeThodS 
3.2.1 design
This study is part of a large cross-sectional study, titled ‘Healthy Ageing and Intellectual 
Disability’ (HA-ID) [5]. Three care-providing organisations in the Netherlands 
participated in the study. These organizations offer low to high level specialised support 
and care to people with ID. Subthemes in this study are: (1) Physical activity and fitness, 
(2) Nutrition and nutritional state, and (3) Mood and anxiety [5]. Assessment of blood 
pressure, serum glucose, serum cholesterol and components of the metabolic syndrome 
was part of the subtheme concerning nutrition and nutritional state. Ethical clearance 
has been provided by the Medical Ethics Committee of the Erasmus Medical Center 
Rotterdam (MEC 2008-234) and by the ethics committees of the participating care-
providing organisations. The study adheres to the Declaration of Helsinki for research 
involving human subjects [56].
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3.2.2 Participants
A full description of details about design, recruitment and representativeness of the sample, 
as well as diagnostic methods, has been published elsewhere [5]. Of the three participating 
organisations, 2150 clients aged 50 years and over were invited to participate. Informed 
consent was provided by 1069 clients or their legal representatives, of whom 1050 clients 
participated in the assessments. This study population was almost representative for the 
total Dutch older ID population receiving formal care or support: only people living 
independently and people aged 80 years and over were underrepresented, women were 
slightly overrepresented [5]. 
3.2.3 data collection
Gender and age were collected from the records of the care-providing organisations. 
Participant characteristics were obtained from medical files and files of the behavioural 
therapists. General practitioners and specialized physicians for people with ID recorded 
etiology (Down syndrome yes /no), cardiovascular risk factors, cardiovascular disease 
and use of medication. Use of blood pressure lowering drugs (antihypertensives C02, 
beta-blockers C07, ACE-inhibitors C09, diuretics C03, selective angiotensin II antagonists 
C09, calcium channel blockers C08), glucose lowering drugs A10, lipid lowering drugs 
C10 and atypical antipsychotic medication (olanzapine N05AH03, risperidone N05AX08 
and quetiapine N05AH04) was noted. 
Participants underwent physical examination and vena puncture by specially trained 
medical assistants. If people showed any kind of (unusual) resistance, measurements were 
immediately stopped and people were considered as non-participants. Blood pressure 
was measured twice using the Omron M7, after at least two minutes of rest in seated 
position. Hypertension was defined as a mean systolic blood pressure ≥ 140 mmHg and/
or a mean diastolic blood pressure ≥ 90 mmHg [78] and/ or the use of blood pressure 
lowering drugs (if a participant used diuretics, diagnosis was checked in the medical file, 
to differentiate between hypertension and heart failure).
Waist circumference was measured over the unclothed abdomen at the narrowest point 
between the costal margin and iliac crest [68]. For men waist circumference ≥ 102 cm 
was classified as obesity, as was ≥ 88 cm for women [79].
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Vena puncture was performed after an overnight fast. Serum was transported frozen, 
stored at -80 degrees Celsius and analyzed at the laboratory of the Erasmus Medical 
Center, which is a reference laboratory, with specific expertise in serum lipid analysis. 
Reference values of the Erasmus Medical Center were used. Diabetes mellitus was 
defined as a fasting serum glucose > 6.1 mmol/l and/or the use of glucose lowering drugs. 
Hypercholesterolemia was defined as a fasting serum total cholesterol > 6.5 mmol/l and/
or the use of lipid lowering drugs. Metabolic syndrome was defined according to the 
criteria of the joint interim statement 2009 [67]. Metabolic syndrome was present if at 
least three of the following five criteria were met: a serum fasting glucose ≥ 5.6 mmol/l 
and/or the use of glucose lowering drugs, serum fasting triglycerids ≥ 1.7 mmol/l and/
or the use of lipid lowering drugs, serum fasting HDL cholesterol ≤ 1.0 mmol/l in men 
and ≤ 1.3 mmol/l in women and/or the use of lipid lowering drugs, waist circumference 
(measured using non-stretchable standard tapes, waist circumference ≥ 94 cm in men and 
≥ 80 cm in women (reference values for overweight in Europeans), and blood pressure 
≥ 130/≥ 85 and/or use of antihypertensive drugs.
To be able to compare our data with previous studies we also present the prevalence of 
metabolic syndrome defined according to the NCEP-ATP III criteria: as the presence of 
at least 3 of the following 5 symptoms: abdominal obesity (waist circumference for men 
> 102 cm, women > 88 cm), insulin resistance (serum fasting glucose ≥ 6.1 mmol/l), 
hypertriglyceridemia (≥ 1.7 mmol/l), low HDL cholesterol (< 1.0 mmol/l in men, < 1.3 
mmol/l in women) and hypertension (blood pressure systolic ≥ 130 and diastolic ≥ 85 
mmHg) [80].
Physical activity was assessed by wearing pedometers for at least four days [32]. We 
classified a minimum of 7500 steps/day as sufficient physical activity [32]. People who 
were not able to participate in pedometry because they were bound to a wheelchair or 
were unable to walk independently, were also classified as physically inactive. Professional 
caregivers were asked about smoking (minimum 1/day), activities of daily living (ADL) 
by Barthel index [61] and Instrumental Activities of Daily Living by Lawton and Brody 
[53, 62].
Comparable data of the Dutch general population are published by the National Institute 
for Public Health and the Environment[81]. A sample of 4513 people, aged 30-70 years, 
underwent physical examination and vena puncture. Data are published age and gender 
specific. Data were extracted for the group aged 50-70, and compared to results from the 
HA-ID study population aged 50-70.
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3.2.4 Statistical analysis
Data were analysed using IBM SPSS Statistics 17.0. Descriptive statistics are provided. With 
chi-square analysis we tested if there were any differences between the study participants and 
the total HA-ID study population in gender, age (age groups 50-59, 60-69, 70-79, 80+), level 
of ID (borderline, mild, moderate, severe, profound) and residential setting (central setting, 
community based or independent with ambulatory support, with relatives). Descriptive 
statistics were used to report prevalence rates of CVD risk factors (aim 1), and to compare 
between measurements in the study, and data from the medical files (aim 2).
To explore associations between hypertension, diabetes, hypercholesterolemia and 
metabolic syndrome (dependent variables) and participant characteristics (correlates); 
gender, age, level of ID, diagnosis of Down syndrome, smoking, residential setting, (I)
ADL items and total score, physical activity, use of atypical antipsychotics and obesity by 
waist circumference (independent variables), univariate logistic regression analyses were 
performed. If an independent variable showed a significant association (p < 0.05) with 
the dependent variable, it was subsequently entered into a multivariate logistic regression 
analysis. Items of ADL and IADL were all entered separately in the univariate analyses. 
From ADL and IADL the separate item or total score that correlated strongest was entered 
in the multivariate model (to prevent multicollinearity). Independent variables were 
entered into the multivariate regression equation simultaneously. Independent variables 
were checked for multicollinearity, using Pearson’s correlation coefficient. If a reasonably 
high correlation existed (> .400), we entered the variables separately in the models, to see 
if any change in associations with the dependent variable or explaining value of the model 
occurred. If this happened, we presented both models in the results section. People with 
missing data on hypertension, diabetes, hypercholesterolemia or metabolic syndrome in 
physical examination or vena puncture were excluded from analysis in that particular model.
3.3 ReSuLTS
3.3.1 Study population
Of the 1050 participants in the total cohort, 980 participated in physical examination 
and/or vena puncture. Mean age was 61.5 years (range 50-93). Characteristics of the 
study population are shown in Table 3.1. Representativeness of the groups of participants 
of physical examination (n = 815), vena puncture (n = 724) and those who fulfilled all 
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assessments of metabolic syndrome (n = 584) are shown in Table 3.2. In the physical 
examination group, people with severe and profound ID, living in central settings were 
underrepresented, whereas people with mild ID, living in community settings were 
overrepresented. This may reflect resistance to or misunderstanding of physical assessments 
and physical disabilities. Moreover, men were very slightly overrepresented. In the vena 
puncture group, people living in central settings were overrepresented and people living in 
community settings and living independently were underrepresented. This was due to the 
fact that some people who did not live in central locations had to travel to the nearest (local) 
laboratory for vena puncture, and some people declined for this reason. The sample of people 
who participated in all assessments required for the diagnosis of metabolic syndrome was 
representative with the exception of an underrepresentation of people with profound ID.
Table 3.1 Characteristics of the study population
N %
Gender (n = 980)
Male 503 51.3
Female 477 48.7
Level of ID (n = 980)
Borderline 30 3.1
Mild 210 21.4
Moderate 476 48.6
Severe 157 16.0
Profound 85 8.7
Unknown 22 2.2
Down syndrome (n = 861) 139 16.1
Smoking (n = 931) 190 20.4
Use of atypical antipsychotics (n = 866) 51 5.9
Table 3.2 Differences between the current study sample and the total HA-ID population
Blood pressure
Chi-square (dF)
Vena puncture
Chi-square (dF)
Metabolic syndrome
Chi-square (dF)
Gender 4.1* (1) .2 (1) 3.6 (1)
Residential setting 35.9*** (3) 19.6*** (3) 3.8 (3)
Age 2.3 (5) .9 (5) 2.8 (4)
Level of ID 40.4*** (5) 11.6* (5) 12.3* (5)
* = p < 0.05; ** = p < 0.01; *** = p < 0.001.
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3.3.2 Prevalence of cardiovascular risk factors
Prevalence of hypertension, diabetes mellitus, hypercholesterolemia and metabolic 
syndrome is presented in Table 3.3. Prevalence of metabolic syndrome defined according 
to the joint interim statement was 44.7% (95% CI 40.7-48.7%) (Table 3.3), whereas defined 
according to the NCEP-ATP III criteria, prevalence was 24.8% (95% CI 21.3-28.3%). 
Prevalence of CVD risk factors in the HA-ID population as compared to the general 
Dutch population [81], both aged 50-70, is presented in Table 3.4. Hypertension and 
metabolic syndrome are less prevalent in men with ID and more prevalent in women 
with ID than in the general population (as determined by the absence of overlap between 
95% confidence intervals). Diabetes is more prevalent in women with ID. The overall 
hypertension, diabetes and metabolic syndrome prevalence does not differ between 
populations. Hypercholesterolemia is less prevalent in men, women and the overall 
ID population, as compared to the general population. To give a complete overview 
of CVD risk factors, prevalence of overweight and obesity (which has been published 
before [68]) is also shown, as compared to the general population aged 50-70 years [81] 
(Table 3.4).
Table 3.3 Prevalence of cardiovascular risk factors
Prevalence % 95% CI
Hypertension
Men (n = 432) 49.8 45.1-54.5
Women (n = 383) 56.7 51.7-61.6
Total (n = 815) 53.0 49.6-56.4
Diabetes mellitus
Men (n = 375) 11.7 8.5-15.0
Women (n = 349) 15.8 11.9-19.6
Total (n = 724) 13.7 11.2-16.2
Hypercholesterolemia
Men (n = 375) 16.5 12.8-20.3
Women (n = 349) 30.1 25.3-34.9
Total (n = 724) 23.1 20.0-26.1
Metabolic syndrome
Men (n = 315) 36.5 31.2-41.8
Women (n = 269) 54.3 48.3-60.2
Total (n = 584) 44.7 40.7-48.7
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Table 3.4 Prevalence of cardiovascular risk factors
ID population aged 50-70 
(95% confidence interval)
General population aged 50-70 
(95% confidence interval)
Hypertension Men (n = 366) 45.4%
(40.3-50.5)
Men (n = 1104) 55.1%
(52.1-58.0)*
Women (n = 319) 53.9%
(48.5-59.4)
Women (n = 1160) 44.0%
(41.1-46.8)*
Total (n = 685) 49.3%
(45.6-53.1)
Total (n = 2264) 49.4%
(47.3-51.4)
Diabetes Men (n = 320) 10.0%
(6.7-13.3)
Men (n = 1063) 10.2%
(8.3-12.0)
Women (n = 291) 15.5%
(11.3-19.6)
Women (n = 1110) 8.0%
(6.4-9.6)*
Total (n = 611) 12.6% 
(10.0-15.2)
Total (n = 2173) 9.1% 
(7.9-10.3)
Hypercholester-
olemia
Men (n = 320) 15.6%
(11.7-19.6)
Men (n = 1088) 36.2%
(33.4-39.1)*
Women (n = 291) 28.9%
(23.7-34.1)
Women (n = 1130) 40.2%
(37.3-43.0)*
Total (n = 611) 21.9% 
(18.7-25.2)
Total (n = 2218) 38.3% 
(36.3-40.3)*
Metabolic 
syndrome**
Men (n = 269) 27.5%
(22.2-32.9)
Men (n = 1074) 44.8%
(41.8-47.8)*
Women (n = 223) 46.2%
(39.6-52.7)
Women (n = 1160) 36.6%
(33.8-39.4)*
Total (n = 492) 36.0% 
(31.7-40.2)
Total (n = 2186) 40.6% 
(38.6-42.7)
Overweight 
(Body Mass 
Index 25-30 \
kg/m²)
Male (n = 387) 39.3%
(34.4-44.1)
Male (n = 1105) 50.7%
(47.7-53.6)*
Female (n = 374) 36.4%
(31.5-41.2)
Female (n = 1158) 35.8%
(33.0-38.5)
Total (n = 761) 37.8% 
(34.4-41.3)
Total (n = 2263) 43.0% 
(41.0-45.1)
Obesity by Body 
Mass Index 
(≥ 30 kg/m²)
Male (n = 387) 12.1%
(8.9-15.4)
Male (n = 1105) 13.9%
(11.9-16.0)
Female (n = 374) 37.2%
(32.3-42.1)
Female (n = 1158) 17.5%
(15.3-19.7)*
Total (n = 761) 24.4% 
(21.4-27.5)
Total (n = 2263) 15.8% 
(14.3-17.3)*
Central 
obesity (waist 
circumference)
Male (n = 392) 24.0%
(19.8-28.2)
Male (n = 1104) 37.0%
(34.2-39.9)*
Female (n = 375) 64.3%
(59.4-69.1)
Female (n = 1162) 50.5%
(47.6-53.4)*
Total (n = 767) 43.7% (40.2-47.2) Total (n = 2266) 43.9% (41.9-46.0)
* Confidence intervals do not overlap between ID population and general population.
** Metabolic syndrome defined according to the joint interim statement criteria [67], but with abdominal 
obesity instead of abdominal overweight (waist circumference ≥ 102 cm in men and ≥ 88 cm in women).
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3.3.3 new diagnoses of cardiovascular risk factors
For 715 of the 815 participants in the physical examination group, medical file data were 
available. Of these 715 persons, 385 met the criteria for hypertension in this study, of which 
191 (50%) had not been previously diagnosed with hypertension (neither in medical file nor 
receiving medication). Of 724 participants in serum glucose measurement, medical file data 
were available for 654 persons, of whom 91 met the criteria for diabetes mellitus in this study. 
Of these 91 persons, 41 (45%) had not been previously diagnosed with diabetes (neither in 
medical file nor receiving medication). Out of 724 participants in serum lipid measurement, 
with 651 with available medical file data, 157 met the criteria for hypercholesterolemia in this 
study. There were 73 persons (46%) with a new diagnosis of hypercholesterolemia (neither 
in medical file nor receiving medication). For 518 of the 584 participants in metabolic 
syndrome assessments, medical file data were available. Of these, 241 met the criteria for 
metabolic syndrome according to the joint interim statement definition. No mention was 
made of metabolic syndrome in the medical files in 226 participants (94%).
3.3.4 Associations with cardiovascular risk factors
Univariate and multivariate associations between client characteristics and hypertension, 
diabetes, hypercholesterolemia and metabolic syndrome are presented in Table 3.5.
3.3.4.1 Associations with hypertension
Independent variables included in the multivariate logistic regression model with 
hypertension were gender, age, level of ID, Down syndrome, (semi-) independent living, 
being able to prepare a meal independently and obesity by waist circumference. Possible 
multicollinearity existed between level of ID, independent living and being able to prepare 
a meal independently. Level of ID and preparing a meal independently were subsequently 
entered in separate models, together with gender, age, Down syndrome and obesity (Table 
3.5). The proportion explained variance of the model (R²) was 0.18 (Table 3.5) and did 
not increase with this intervention, whereas significance and ORs of the other variables 
did not change significantly either.
The following groups were significantly more at risk of having hypertension: people 
with higher age, people with other causes of ID than Down syndrome, people who lived 
more independently, people who were able to do groceries independently and people 
who were obese.
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3.3.4.2 Associations with diabetes mellitus
Independent variables included in the multivariate logistic regression model with diabetes 
were age, level of ID, Down syndrome, being able to do groceries independently (IADL) 
and obesity by waist circumference. Possible multicollinearity existed between level of 
ID and being able to do groceries independently. These two independent variables were 
subsequently entered in separate models, together with age, Down syndrome and obesity. 
The proportion explained variance of the model (R²) was 0.10 (Table 3.5) and did not 
change significantly with this intervention. The OR of ‘absence of Down syndrome’ 
changed if ‘being able to do groceries independently’ was left out of the analysis. Other 
independent variables did not change significantly.
Significantly more at risk of having diabetes were people with a less severe ID, people 
with other causes of ID than Down syndrome and people who were able to do groceries 
independently.
3.3.4.3 Associations with hypercholesterolemia
Independent variables included in the multivariate logistic regression model with 
hypercholesterolemia were gender, age, level of ID, Down syndrome, (semi-)independent 
living, being able to eat independently (ADL), being able to do groceries independently 
(IADL), use of atypical antipsychotics and obesity by waist circumference. Possible 
multicollinearity existed between level of ID, independent living, being able to eat 
independently (ADL) and being able to do groceries independently (IADL). These four 
independent variables were subsequently entered in separate models, together with 
gender, age, Down syndrome, use of atypical antipsychotics and obesity. The proportion 
explained variance of the model (R²) was 0.15 (Table 3.5) and did not increase with 
this intervention, and significance and ORs of the other variables did not change 
significantly.
The following groups were significantly more at risk of having hypercholesterolemia: 
females, people with a less severe ID, people who lived more independently, people who 
were able to eat (ADL) or do groceries (IADL) independently and people who were obese.
3.3.4.4 Associations with the metabolic syndrome
Independent variables included in the multivariate logistic regression model with the 
metabolic syndrome were gender, age, level of ID, Down syndrome and being able to 
do groceries independently (IADL). Bivariate correlations between the independent 
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variables did not indicate risk of multicollinearity. The proportion explained variance 
of the model (R²) was 0.19 (Table 3.5).
Significantly more at risk of having the metabolic syndrome were females, people with 
higher age, a less severe ID, with other causes of ID than Down syndrome and people 
who were able to do groceries (IADL) independently.
3.4 dISCuSSIon
This study into cardiovascular risk factors of 980 older people with intellectual disabilities 
(ID) in a near-representative population showed that hypertension (53.0%), diabetes 
(13.7%), hypercholesterolemia (23.1%) and metabolic syndrome (44.7%) are significant 
problems within this population. In the study population, individual cardiovascular risk 
factors had not been previously diagnosed in 45-50%, whereas the metabolic syndrome 
had not been diagnosed in 94%. People who are more at risk, apart from females, people 
with higher age and people with obesity, are people with other causes of ID than Down 
syndrome, people with less severe ID, people who live more independently and are 
able to do groceries and prepare a meal by themselves. Surprisingly, we did not find a 
correlation with the use of atypical antipsychotics. The proportion explained variances 
(R²) of the models of all CVD risk factors was very low, which means that the population 
risk is not fully explained by the correlates included in the models, and there may be 
other influences that we did not take into account in the present study (for example diet 
and genetic influences).
Prevalence of hypertension, diabetes and metabolic syndrome does not differ from 
prevalence in the general Dutch population of the same age. However, more females 
were affected in the ID population than in the general population, and the reverse was 
true for males [81]. In the general population, 23% of people with diabetes in the study 
were not previously diagnosed with this condition [81], whereas in people with ID there 
were almost twice as much missed diagnoses (45%). Hypercholesterolemia was present 
less often than in the general population [81].
The prevalence of hypertension was higher than the 36.8% (95% CI 32.3-41.3) found in our 
previous study in 470 older people with ID receiving care by specialized ID physicians from 
three care providing organizations, and prevalence of diabetes was similar (8.8%, 95% CI 
6.2-11.4) [21]. In the present study we found a lower prevalence of hypercholesterolemia 
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than in the previous study (31.9%, 95% CI 27.6-36.1). However, in that study blood 
samples had been analyzed in three laboratories and women were overrepresented [21], 
whereas we have shown that women have a higher risk. This warrants concern about 
hypercholesterolemia in older women with ID. Other studies in older people with ID 
showed an equal [20, 28] or lower [26, 27] prevalence of hypertension, diabetes or 
hypercholesterolemia, but these studies were all based on chart reviews or interviews, 
which unavoidably results in an underestimation of the prevalence, due to underdiagnosis. 
No previous studies have been published, investigating the prevalence of metabolic 
syndrome according to the joint interim statement criteria in older people with ID. Also, 
effects of metabolic syndrome according to these new criteria on CVD morbidity and 
mortality has not yet been evaluated in long term cohort studies. Prevalence according 
to the NCEP-ATP III criteria was exactly comparable to the only previous study [25].
Strengths of the present study are the large sample size and the presence of all levels of ID 
in the sample. The fact that all blood samples were analyzed in one reference laboratory 
with specific expertise in serum lipid analyses is an additional strength. Furthermore, 
included correlates were studied extensively and according to current statistical insights.
Weakness of the present study is that we draw conclusions on hypertension based on 
two consecutive measurements on the same day, whereas in clinical practice, a single 
elevated blood pressure outcome would require repeated measurement a few days later, 
before a diagnosis of hypertension would be made. This could have resulted in an over 
estimation of the prevalence of hypertension due to stress-related high blood pressure, 
caused by the test environment or procedure. However, in other studies this method 
has been used before [21, 81, 82]. Another limitation was that we compared our data to 
published data from the general population and we did not have comparable data for 
the group aged over 70 years. 
In conclusion, cardiovascular risk factors occur as much in older people with ID as in 
older people in the general population in the Netherlands, but these risk factors remain 
more often unnoticed. This serious population risk has important implications for 
cardiovascular disease prevention policy.
First of all, detection of cardiovascular risk factors is currently insufficient. The high 
amount of missed diagnoses shows that people with ID are not able to address their 
symptoms (in case of diabetes) or worries adequately. Professional caregivers, who know 
these people best, should be educated on cardiovascular risk factors, in order to support 
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clients in their need for help. Moreover, physicians should actively screen this group for 
CVD risk factors. We recommend that physicians screen all people with ID aged 50 years 
and over at least once in five years for CVD risk factors, and are aware of the diagnosis of 
metabolic syndrome, which warrants a very active treatment policy. Treatment of CVD 
risk factors should occur according to current standards.
Prevention of CVD risk factors is the second important issue. Lifestyle could be improved 
in many cases. Since physical activity level is extremely low in older people with ID [32], 
care-providing organisations should promote physical activity through education and 
supporting programs. Furthermore, teaching people about healthy diets and supporting 
them in choosing healthy food and preparing healthy meals is needed. We have shown 
that people who live and function more independently in these areas, are specifically at 
risk, and therefore deserve to be supported.
We did not find an association with the use of atypical antipsychotics, probably because of 
lack of statistical power, and also because we did not have information on the duration of 
treatment. Indeed, we have observed in clinical practice that there may be an association 
between use of atypical antipsychotics and the metabolic syndrome. Physicians should 
be very cautious in prescribing atypical antipsychotics in older people with ID for other 
reasons than psychosis (e.g. challenging behavior, and behavioral problems in people 
with autism) [35].
Policy for future research is needed. Explained variance in the analyses of the investigated 
CVD risk factors was very low, which means that not all influences were identified in 
the present study. We did not study familiar occurrence of CVD risk factors, but genetic 
factors may very well be an important factor. Further fundamental research is needed 
to explore the origin of the CVD risk in older people with ID. Another question that 
remains unanswered in the present study is what the presented cardiovascular risk 
factors, and the two measures of metabolic syndrome, as part of the total risk profile, 
mean for future morbidity and mortality in older people with ID. This question needs 
to be answered prospectively. 
Joint effort of policy makers, clinicians, caregivers and scientists is needed in order to 
effectively prevent, detect and treat CVD risk factors and consequent morbidity and 
mortality in older people with ID.
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ABSTRACT
Older people with an intellectual disability (ID) have been shown to have similar to 
increased cardiovascular risks as compared to the general population. Peripheral 
arterial disease (PAD), atherosclerosis distal from the aortic bifurcation, is associated 
with increased cardiovascular morbidity and mortality. The prevalence of PAD has 
not been investigated in this population. Therefore, the aim of the present study was 
to determine the prevalence of PAD in older people with ID in The Netherlands, 
the rate of prior diagnoses, and correlations with participant characteristics, and to 
compare the prevalence with PAD in the general Dutch population. 771 people aged 
50 years and over participated in ankle-brachial index (ABI) measurement as part of 
a multi-centre cross-sectional study (HA-ID study). PAD was defined as an ABI < 
0.9. After excluding those, who met the exclusion criteria, 629 participants remained. 
PAD was present in 20.7% of the participants and 97% had not been diagnosed before. 
People with higher age, smokers and people who lived in central settings, walked 
with support and were more dependent in activities of daily living were more at risk 
of PAD. Prevalence of PAD is higher than in the general population (17.4% of 562 
eligible participants with ID, as compared to 8.1% of 917 Dutch participants of the 
PANDORA study, a pan-European study into the prevalence of PAD) through all 
age groups. Because the high prevalence of PAD implies a serious health risk for 
older people with ID, we recommend that ankle-brachial index measurement is to 
be routinely performed as part of the cardiovascular risk management in this group.
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4.1 InTRoduCTIon 
With increasing longevity, older people with an intellectual disability (ID) have been shown 
to have similar to increased cardiovascular risks as compared to the general population 
[8, 9, 21, 25, 68]. A low ankle-brachial index (ABI) indicates peripheral arterial disease 
(PAD), atherosclerosis distal from the aortic bifurcation. PAD also indicates generalized 
atherosclerosis [41]. Although PAD is often asymptomatic [83, 84], longitudinal studies 
have proven an increased risk of cardiovascular morbidity, cardiovascular mortality and 
total mortality [41-43].
Risk factors for peripheral arterial disease are smoking, obesity, hypertension, hypercholes-
terolemia, metabolic syndrome, physical inactivity and impaired lower extremity 
functioning [85-87]. Smoking among people with ID increases [16]. In the HA-ID study, 
20% of the participants smoked, which is exactly as much as in the same aged general 
population in The Netherlands [81]. Furthermore, the metabolic syndrome and it’s 
components occur as much as in the general population [21, 24, 25, 88]. Obesity is present 
more often than in the general population, probably due to lifestyle related factors and use 
of medication (i.e. atypical antipsychotic drugs) [68]. Moreover, physical activity levels are 
very low in older people with ID [31, 32] and impaired mobility is often present, either 
from early age on, as part of the genetic syndrome or cause of the ID, or acquired later in 
life [53]. Thus, PAD may be expected to occur similarly or more often than in the general 
population, which can cause current disease symptoms, but can also indicate a future 
morbidity and mortality risk. Until now PAD has not been studied in people with ID.
Therefore, we studied prevalence of PAD using the ABI in older people with ID, how often 
these cases had been diagnosed before this study, and its associations with participant 
characteristics that are related to cardiovascular disease risks (gender, age, level of ID, 
Down syndrome, mobility, residential setting, (instrumental) activities of daily living, 
smoking, physical activity, use of atypical antipsychotics, obesity, hypertension, diabetes, 
hypercholesterolemia and metabolic syndrome) [68, 88]. Furthermore, prevalence of 
PAD in older people with ID was compared to the prevalence of PAD in the older general 
Dutch population.
4.2 MeThodS 
This study is part of a large cross-sectional study, titled ‘Healthy Ageing and Intellectual 
Disability’ (HA-ID). A full description of details about design, recruitment and 
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representativeness of the sample, as well as diagnostic methods, has been published 
elsewhere [5]. Of three Dutch care-providing organisations, 1050 clients participated in 
the study. This study population was nearly representative for the total older ID population 
receiving formal care or support. Ethical clearance was provided by the Medical Ethics 
Committee of the Erasmus Medical Center Rotterdam (MEC 2008-234) and by the ethics 
committees of the participating care providing organizations. The study adheres to the 
Declaration of Helsinki for research involving human subjects [56].
Participants underwent physical examination by specially trained medical assistants or 
specially trained nurses. People sitting in wheelchairs were excluded, because they could 
not be examined in the supine position. Systolic blood pressure was measured at rest 
once, using the Omron M7 on the left arm in the supine position. The blood pressure at 
the anterior or tibial posterior arteries was measured once at both ankles using a Doppler 
ultrasonic instrument with an 8-MHZ vascular probe (Boso classico and Huntleigh MD 
II). ABI was calculated by dividing the mean of the two ankle measurements by the arm 
measurement [89, 90]. PAD was classified as an ABI <0.9, whereas an ABI 0.9-0.99 was 
considered as borderline PAD [41, 91]. Participants with an ABI ≥1.3 were excluded from 
further analysis, because this is an indication of poor arterial compressibility, resulting 
from arterial stiffness or calcification, which could be related to diabetes [41, 91].
Data were analyzed using IBM SPSS Statistics 17.0. With a chi-square test we explored 
the representativeness of the participants in ABI measurements as compared to the total 
HA-ID study population in gender, age (age groups 50-59, 60-69, 70-79, 80+), level of 
ID (borderline, mild, moderate, severe, profound) and residential setting (three groups: 
central setting, community based, independent with ambulatory support or living with 
relatives).
Associations between PAD (dependent variable) and the following participant characte-
ristics were explored: gender, age, level of ID, diagnosis of Down syndrome, smoking, 
residential setting, (instrumental) activities of daily living ((I)ADL) total score and 
individual item scores of ADL eating and IADL preparing meal and IADL doing 
groceries, physical inactivity (less than 7500 steps/day), use of atypical antipsychotics, 
abdominal obesity, hypertension, diabetes, hypercholesterolemia and metabolic syndrome 
(independent variables). Diagnostic methods and criteria of independent variables have 
been published elsewhere [32, 53, 68, 88]. Independent variables showing a significant 
association (p < 0.05), or trend (p = 0.05) towards significance with the dependent variable 
in a univariate regression analysis, were simultaneously entered into a multivariate logistic 
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regression analysis. Independent variables were checked for multicollinearity, using 
Pearson’s correlation coefficient (with a correlation > 0.4 between independent variables 
indicating possible multicollinearity).
For comparison with the general population, aggregated data of Dutch participants of 
the PANDORA-study were used. In the PANDORA study, a cross-sectional European 
study, the prevalence of PAD was studied in people with ≥ 1 cardiovascular risk factor, 
but without a prior diagnosis of PAD or cardiovascular disease [92]. Inclusion criteria for 
participants in the PANDORA study were: men aged 45 years and over and women aged 
55 years and over, with at least one of the following cardiovascular risk factors: cigarette 
smoking, hypertension, low high-density-lipoprotein-cholesterol or high low-density-
lipoprotein-cholesterol, family history of premature coronary heart disease or elevated waist 
circumference. Participants were excluded if they had symptoms of PAD identified by the 
physician, diabetes mellitus or cardiovascular disease or equivalents (transient ischaemic 
attacks, stroke, aortic aneurism) [92]. In order to compare the data of HA-ID participants 
with the Dutch PANDORA participants, the same exclusion criteria were applied to the 
HA-ID population for this analysis. The HA-ID population also included participants 
without cardiovascular risk factors, and for the HA-ID population no data were available on 
family history. Comparison between the prevalence of PAD in the HA-ID population and 
the aggregated data of the Pandora study was performed using confidence intervals [93].
4.3 ReSuLTS
Of the 1050 HA-ID participants, 771 clients participated in ankle-brachial measurement. 
Forty-eight were excluded from the analyses because of an ABI ≥1.3, indicating arterial 
stiffness, and 105 were excluded because they were in a wheelchair, resulting in 629 
study participants with a mean age of 61.5 years (range 50-93). Participant characteristics 
are presented in Table 4.1. As compared to the total HA-ID population, people living 
in community settings were overrepresented and people living in central settings 
underrepresented. Furthermore, people with borderline, mild ID and moderate ID were 
overrepresented whereas people with severe and profound ID were underrepresented. 
This reflects varying cooperation in physical examination of people with more severe ID 
and the exclusion of people in wheelchairs, which means that a functionally more able 
group participated in the study. Gender and age-groups were equally represented as in 
the total HA-ID population.
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4.3.1 Prevalence of PAd
Total prevalence of PAD was 20.7% (95% CI 17.5-23.8), whereas borderline PAD was 
found in 25.4% (95% CI 22.0-28.8). The total prevalence of PAD and prevalence for each 
participant characteristic is shown in Table 4.1. For 517 participants medical file data 
were available, of whom 112 were found to have PAD in this study. Three out of these 
112 participants, (2.6%) had been diagnosed with PAD prior to the study, which means 
that there were 97.4% previously unidentified cases.
Table 4.1 Prevalence of PAD according to participant characteristics
PAD
Participant characteristic 
(n = data available)
(N) Percentage of total 
study population
Prevalence 
of PAD
95% CI
Total study population (n = 629) (629) 100% 20.7% 17.5-23.8%
Gender (n = 629)
Male (337) 53.6% 21.1% 16.7-25.4%
Female (292) 46.4% 20.2% 15.6-24.8%
Age (n = 629)
50-59 (300) 47.7% 17.0% 12.8-21.3%
60-69 (220) 35.0% 20.9% 15.5-26.3%
70-79 (95) 15.1% 29.5% 20.3-38.6%
80+ (14) 2.2% 35.7% 10.6-60.8%
Down syndrome (n = 541) (69) 12.8% 18.8% 9.6-28.0%
Level of ID (n = 610)
Borderline (25) 4.1% 24.0% 7.3-40.7%
Mild (152) 24.9% 20.4% 14.0-26.8%
Moderate (323) 53.0% 20.4% 16.0-24.8%
Severe (82) 13.4% 20.7% 12.0-29.5%
Profound (28) 4.6% 21.4% 6.2-36.6%
Residential setting (n = 629)
Central setting (283) 45.0% 24.7% 19.7-29.8%
Community based (305) 48.5% 17.4% 13.1-21.6%
Independent or with relatives (41) 6.5% 17.0% 5.6-28.6%
Mobility (n = 600)
Walking independently (504) 84.0% 19.0% 15.6-22.5%
Walking with support (96) 16.0% 33.3% 23.9-42.8%
Smoking (n = 599) (151) 25.2% 28.5% 21.3-35.7%
Use of atypical antipsychotics (n = 547) (34) 6.2% 35.3% 19.2-51.4%
Physical inactivity (n = 300) (219) 73.0% 22.4% 16.9-27.9%
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4.3.2 Associations of PAd
Independent variables included in the multivariate logistic regression model were age, 
residential setting, smoking, mobility, ADL score and use of atypical antipsychotics (Table 
4.2). Possible multicollinearity existed between residential setting, mobility and ADL 
score. Therefore, residential setting, mobility and ADL score were subsequently entered 
Table 4.2 Univariate and multivariate logistic regression analysis of PAD
Independent variable 
(n = participants in measurement)
Univariate Multivariate OR 
(95% CI)
Multivariate separate 
models OR (95% CI)
Gender (n = 629) -
(Higher) age (n = 629) ** 1.33 (1.03-1.71)*
(Less severe) level of ID (n = 610) -
Presence of Down Syndrome (n = 541) -
Residential setting (higher risk for people 
in central settings) (n = 629)
* 1.28 (0.86-1.91) 1.46 (1.00-2.13)* †¹
Smoking (n = 599) * 1.20 (1.05-1.38)*
Less independent mobility (walking with 
support) (n = 600)
** 1.57 (0.93-2.65) 1.89 (1.18-3.02)** †²
ADL total score (less independent 
functioning) (n = 600)
* 1.04 (0.98-1.10) 1.07 (1.02-1.13)** †³
ADL eating (n = 600) -
IADL total score (n = 600) -
IADL groceries (n = 600) -
IADL preparing meal (n = 600) -
Atypical antipsychotics (n = 547) p = 0.052 1.85 (0.86-4.01)
Physical inactivity (n = 300) -
Obesity (waistcircumference) (n = 624) -
Hypertension (n = 608) -
Hypercholesterolemia (n = 474) -
Diabetes (n = 474) -
Metabolic syndrome (n = 474) -
R²: 0.73; - = univariate not significant; * = p < 0.05; ** = p < 0.01; *** = p < 0.001.
† = Results from multiple logistic regression analysis in a separate model, because multicollinearity was 
a problem in the first multivariate model.
¹ = Age, smoking, use of atypical antipsychotics and living less independently were entered in the 
model; ² = Age, smoking, use of atypical antipsychotics and less independent mobility (walking with 
support) were entered in the model; 
³ = Age, smoking, use of atypical antipsychotics and functioning less independently (ADL) were entered 
in the model.
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in separate models, together with age, smoking and use of atypical antipsychotics. The 
proportion explained variance of the model (R²) was 0.73 (Table 4.2) and did not change 
with this intervention, whereas odds ratios of the other variables in the analysis did not 
change significantly either. Groups that were significantly more at risk of PAD, were 
people with higher age, people who smoked, people who lived in central settings, people 
who walked with support and people with less independent functioning on ADL score.
4.3.3 Comparison with the general population
After excluding 105 people in a wheelchair, 63 people with diabetes and 41 people with 
established PAD or cardiovascular disease, 562 HA-ID participants remained (of the 
original 771) for comparison with the data of 917 Dutch PANDORA participants aged 
50 years and over [86]. For the total group and the age groups 50-59, 60-69 and 70-79 
prevalence of PAD was significantly higher in the ID population than in the general 
population (Table 4.3). The group aged 80 years and over of the HA-ID population was 
too small to draw conclusions.
Table 4.3 Prevalence of PAD in the HA-ID population without established PAD or cardiovas-
cular disease as compared to the prevalence in the Dutch PANDORA participants [86], 
according to age
HA-ID PANDORA
n PAD prevalence (95% CI) n PAD prevalence (95% CI)
50-59 284 15.9% (11.6-20.1)* 213 6.6% (3.2-9.9)
60-69 198 17.2% (11.9-22.4)* 388 7.5% (4.9-10.1)
70-79 70 24.3% (14.2-33.3)* 237 9.3% (5.6-13.0)
80+ 10 20.0% 49 16.33% (6.0-26.7)
Total 562 17.4% (14.3-20.6)* 917 8.1% (6.3-9.8)
* Confidence intervals do not overlap between ID population and general population.
4.4 dISCuSSIon
This is the first study to investigate peripheral arterial disease (PAD) in older people with 
intellectual disability (ID) in The Netherlands, using the ankle-brachial index (ABI). 
With a total prevalence of 20.7%, PAD is highly present. It had not been diagnosed prior 
to the study in 97% of the cases. People with higher age, smokers and people living in 
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central settings, walked with support and were more dependent in activities of daily living 
(ADL) were more at risk. No association was found with other cardiovascular disease 
(CVD) risk factors.
The prevalence of PAD in older people with ID is significantly higher than in the 
general Dutch population through all age groups. Possible explanations for the increased 
prevalence are the high amount of people with impaired mobility among this group [31, 
32], the widespread unhealthy lifestyle [21], and subsequent obesity [17-19, 68], which 
leads to vascular disease later in life. It has been shown that frailty in people with ID 
aged 50-64 occurs as much as in the general population aged 65 and over [94]. Moreover 
sarcopenia is highly prevalent [95]. Thus, due to metabolic changes in muscle tissue and 
an accumulation of adverse conditions, higher occurrence of PAD might be conceivable. 
But PAD may also be one of the causes of these conditions. 
Most cases of PAD had remained unrecognized. Although PAD is often asymptomatic, the 
high rate of new diagnoses suggests that people who did experience pain or discomfort 
but were unable to communicate that, had remained undiagnosed too.
As could be expected, people with higher age and people who smoked were more 
at risk of PAD [86, 87]. People living in central settings, with impaired mobility and 
less independent ADL functioning were also more at risk. These are probably people 
with declining health, who for this reason are less able to take care of themselves in 
the community, and have moved to residential settings with a higher level of support. 
Cardiovascular disease may be a part of their physical problems, but PAD may also result 
from the declined mobility and low levels of physical activity [85]. Because of the cross-
sectional design of the study, it is not possible to provide information about the direction 
of the causal relationship between impaired mobility and PAD. 
The use of atypical antipsychotics was not significantly related to PAD, possibly due 
to lack of statistical power, because the univariate analysis was near-significant. We do 
expect atypical antipsychotics to be associated with PAD, because these are a relevant 
causal factor for the metabolic syndrome and increased CVD risk factors [73]. This has 
an implication for clinical practice, since use of (atypical) antipsychotics is high [35], and 
discontinuation significantly improves metabolic changes [40]. Unexpectedly, other CVD 
risk factors (obesity, hypertension, diabetes, hypercholesterolemia, metabolic syndrome) 
could not be proven to be correlated to PAD in this study. Some risk factors may be treated 
adequately, as there was no information on duration of treatment.
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Strengths of the present study were the relatively large sample and the inclusion of a 
complete set of correlates, which led to a high proportion explained variance (R² = 0.73). 
Limitations were the exclusion of people in wheelchairs, which is the most vulnerable 
group, and low participation of the eldest group, which could lead to an underestimation 
of the total population prevalence. For comparison with the general population we 
used aggregated data from the Pandora study. We chose to compare with the data from 
the Dutch participants of the Pandora study only, because the Pandora study shows 
us that there are large differences of the prevalence of PAD between countries within 
Europe, possibly due to differences in ethnicity, culture and lifestyle [86]. There were 
two differences in inclusion between the HA-ID study and the Pandora study. In the 
HA-ID study also people without CVD risk factors had been included, in contrast 
to the PANDORA participants with at least one known CVD risk factor. This makes 
the estimation in the HA-ID population more conservative. Moreover, in the group 
aged 50-59, the Pandora study did not include women aged 50-54. This could give an 
overestimation of the prevalence in this age-group in the Pandora study, as compared to 
the HA-ID study. However, in the HA-ID study, we did not find a significant difference 
between the prevalence of PAD in men and women. Both these differences in inclusion 
might only underestimate the increased prevalence in the ID population as compared 
to the general population.
In conclusion, PAD is highly prevalent among older people with ID and is clearly more 
prevalent than in the general Dutch population of comparable age. This implies a serious 
health risk for older people with ID. Apart from people with higher age and people who 
smoke, older people with impaired mobility and less independent functioning are more 
at risk, and require intensive medical attention and effort to improve their mobility. 
We recommend that ABI measurements are performed as part of the cardiovascular 
risk management in people with ID, especially because most people with PAD were 
not previously diagnosed. Longitudinal research should address the consequences for 
cardiovascular morbidity and mortality of PAD diagnosed in this group.
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ABSTRACT
Background: Depression, anxiety, diabetes and cardiovascular risk factors are 
fre quent health problems among older people with intellectual disability (ID). 
These conditions may be bidirectionally related. Depression and anxiety may have 
biological effects causing glucose intolerance, fat accumulation and also lifestyle 
changes causing metabolic syndrome. But also the effects of diabetes, metabolic 
syndrome and subsequent cardiovascular disease may affect mood and anxiety. 
This study investigated the association between depression, anxiety and diabetes 
and cardiovascular risk factors in older people with intellectual disabilities.
Methods: The healthy ageing in intellectual disability-study (HA-ID study) is a 
cross-sectional study among people aged 50 years and over with ID, receiving 
formal ID care. Screening instruments for symptoms of anxiety and depression 
were completed and physical examination and vena-puncture were performed to 
establish components of the metabolic syndrome, peripheral arterial disease and 
c-reactive protein.
Results: Of the 990 people who participated, 17% had symptoms of depression 
and 16% had symptoms of anxiety. Type I diabetes was present in 1%, type II 
diabetes in 13% of the study population. Metabolic syndrome, central obesity, 
hypercholesterolemia and hypertension were present in 45%, 48%, 23% and 53% 
respectively. In a multivariate logistic regression analysis a significant association 
was found between increased anxiety symptoms and diabetes only (OR 2.4, 95% 
CI 1.2-4.9).
Conclusions: Increased anxiety symptoms and diabetes are related in older people 
with ID. This association may be bidirectional. No other associations of depression 
and anxiety symptoms with cardiovascular risk factors could be proven to be 
significant. Therefore, more research is needed to unravel the mechanisms of stress, 
mood disorders and cardiovascular disease in older people with ID. To provide 
comprehensive care for older people with ID, screening for diabetes and components 
of the metabolic syndrome in people with anxiety or mood disorders, and screening 
for symptoms of anxiety or depression in people with diabetes is warranted.
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5.1 InTRoduCTIon 
Depression, anxiety, diabetes and cardiovascular disease (CVD) risks are major health 
challenges among older people with intellectual disabilities (ID) [68, 88, 96]. The 
relationships between these conditions were not studied before in the ID population. 
In the general older population, these conditions have been shown to be related. 
Depression is bidirectionally related to diabetes [44], CVD [46] and the metabolic 
syndrome (a combination of CVD risk factors: abdominal obesity, insulin resistance, 
hypercholesterolemia –a high serum cholesterol- and hypertension –high blood pressure-) 
[47]. Effects of cardiovascular pathology on mood and vice versa can be identified on 
different levels, from depressing effects of preclinical pathology such as inflammation, 
atherosclerosis and disturbed glucose homeostasis to psychological effects of lifestyle, 
obesity, diabetes and cardiac disease. The underlying mechanism is that depression causes 
neuro-endocrine effects (e.g. dysregulation of the hypothalamic-pituitary-adrenal cortex 
axis and sympathetic nervous system activation), resulting in abdominal fat accumulation, 
impaired glucose tolerance and high blood pressure [44, 46, 47]. Moreover, people 
with depression tend to have poor health behavior (e.g. unhealthy diet, smoking, sleep 
disturbance and low physical activity) [44, 47]. In the opposite direction, increased levels 
of inflammatory cytokines (proteins involved in the inflammatory response), such as 
c-reactive protein, through atherosclerotic plaques in the blood vessels may be involved 
in depressed mood [44, 47]. Disturbed glucose homeostasis [47] and vascular damage 
may also lead to mood disturbance [44, 47]. Further, obesity and a sedentary lifestyle 
may result in low self-esteem and depression [47], whereas diabetes and cardiovascular 
disease may result in fear and a sense of loss. Moreover, changes in lifestyle, which are 
necessary to avoid further health complications, may be difficult to accept and to include 
in daily life [44, 46]. Similar mechanisms have been suggested for anxiety, but this has 
been investigated less thoroughly and results are more inconclusive [97-100]. Especially 
diabetes may occur more often in people with anxiety symptoms [45].
Research in this area among people with ID is very scarce and limited to conflicting 
results on obesity and depression. Adolescents with ID and obesity were more likely to 
experience depression than those with a healthy weight [54]. The prevalence of depression 
and low self-esteem seemed to be higher among overweight adolescents [101]. However, 
no association was found between depression and obesity in a cohort of adults with ID 
[102]. The relationship between depression and other CVD risk factors, or diabetes has 
not been investigated. The same applies to the relationship between anxiety and CVD 
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risk factors and diabetes. Although CVD risk factors increase with age, no studies on 
these associations are available for older people with ID. Moreover, the mediating role of 
use of antipsychotic drugs, which are widely used among older people with ID and can 
have metabolic side-effects [35], such as obesity and diabetes [55], has not been taken 
into account in these mechanisms.
In (older) people with Down syndrome, different mechanisms may affect these rela-
tionships. Although people with Down syndrome are more often obese [68] and have 
higher body fat percentages from early age on [103, 104], they have less other CVD risk 
factors [88] and less often atherosclerotic CVD [105] than people with other causes of ID. 
Moreover, Down syndrome is associated with early dementia [106], in which symptoms 
can resemble depressive symptoms.
Therefore, the aim of the present study was to explore the relationship between symptoms 
of anxiety and depression, and cardiovascular risk factors (obesity, body fat percentage, 
diabetes, hypercholesterolemia, hypertension, metabolic syndrome, smoking, c-reactive 
protein, and peripheral arterial disease) in older people with ID.
5.2 MeThodS 
5.2.1 design
This study is part of a large cross-sectional study, titled ‘Healthy Ageing and Intellectual 
Disability’ (HA-ID) [5]. Three care-providing organizations in the Netherlands 
participated in the study. These organizations offer low to high level specialized support 
and care to people with ID. Subthemes in this study are: (1) Physical activity and 
fitness, (2) Nutrition and nutritional state, and (3) Mood and anxiety [5]. Assessment 
of associations between depression, anxiety and cardiovascular risk factors was part of 
themes two and three.
5.2.2 Participants
There were 2322 clients aged 50 years and over in the three participating organizations, 
of whom 2150 were invited to participate (178 were not invited to participate, because 5 
were seriously ill, 86 passed away, 39 moved and from 42 data were incomplete at start). 
Informed consent was provided by 1069 clients or their legal representatives (856 people 
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did not give consent and consent was missing for 225 people). 1050 clients participated in 
the assessments of the HA-ID study (19 clients did not participate, because 13 passed away, 
2 were seriously ill and for 4 clients consent was received too late) [5]. Subsequently, 990 
participants completed the mood and anxiety assessments (as required for the present study). 
5.2.3 data collection
Participant characteristics were obtained from medical files. General practitioners and 
specialized ID physicians completed a questionnaire on their clients health issues and 
also recorded etiology (Down syndrome yes /no) and use of medication (for diabetes, 
hypercholesterolemia, hypertension, and atypical antipsychotic drugs: olanzapine, 
risperidone and quetiapine). Behavioural therapists recorded level of ID from their files. 
Depression and anxiety have been defined as increased depressive or anxiety symptoms 
measured with screening tools. We have not used psychiatric diagnoses, because those 
were not available for the complete study population. Depressive symptoms were measured 
using two screening instruments. Participants capable of self-report completed the 
Inventory of Depressive Symptomatology Self Report (IDS-SR) [107]. For participants 
who were not capable of self-report, professional care-givers who knew the participant 
for at least three months, completed the Dutch informant-report Signalizing Depression 
List (SDL-ID) [108]. In people with ID, the IDS-SR has a good internal consistency and 
test-retest reliability (α = 0.89 and ICC = 0.91), and the validity is satisfactory (sensitivity 
71% and specificity 54%) [109]. Its score ranges from 0 to 84. We used a cut-off score of 
≥ 18 [110]. The SDL-IDs internal consistency and interrater reliability in older people 
with ID are good (α = 0.77 and r = 0.87) [111]. The score on the SDL-ID ranges from 
18 to 72. We used a cut-off score of ≥ 35 [112]. In a pilot study, the IDS-SR and SDL-ID 
were completed both for 23 participants, showing 100% correspondence for the used 
cut-off scores.
Screening of anxiety symptoms was performed using three screening instruments 
[96]. All participants were screened with an informant-report instrument, the Anxiety, 
Depression, And Mood Scale (ADAMS) (the whole instrument was completed, but for the 
present study only the general anxiety subscale was used) [113]. This subscale’s internal 
consistency, test-retest reliability and interrater reliability are good (α = 0.88, ICC = 0.86 
and ICC = 0.74) and its validity is satisfactory (sensitivity 80-82% and specificity 65-78%) 
in older people with ID [114]. The score on the general anxiety subscale ranges from 
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0 to 21. We used cut-off scores ≥ 10 for people without autism and ≥ 14 for those with 
an autism spectrum disorder [114]. In addition to the ADAMS, participants who were 
capable of self-report were screened with the Glasgow Anxiety Scale for People with an 
Intellectual Disability (GAS-ID) [115] and the Anxiety subscale of the Hospital Anxiety 
and Depression Scale (HADS-A) [31, 116]. The internal consistency and reliability of 
the GAS-ID are good (α = 0.86 and ICC = 0.89) and its validity sufficient (sensitivity 
84% and specificity 52%) [115]. Its score ranges from 0 to 54. We used a cut-off score of 
≥ 17 [117]. The HADS-A has fair to good psychometric properties [118, 119]. Its score 
ranges from 0 to 21, we used a cut-off score of ≥ 8 [119]. Anxiety was defined as a score 
above cut-off on at least one of the anxiety questionnaires [96].
Participants underwent physical examination to assess blood pressure [88], ankle-brachial 
index [120], waist-to-hip ratio (WHR) and body fat percentage [68]. Methods of physical 
examination are in Table 5.1.Vena puncture was performed after an overnight fast, to 
assess serum glucose, serum cholesterol and c-reactive protein (crp) [88]. Serum was 
transported frozen, stored at -80 degrees Celcius and analyzed at the laboratory of the 
Erasmus Medical Center. Reference values of the Erasmus Medical Center were used 
for cut-off scores for glucose and cholesterol in serum. Diabetes mellitus was defined 
as a fasting serum glucose > 6.1 mmol/l and/or the use of glucose lowering drugs. 
Hypercholesterolemia was defined as a fasting serum total cholesterol > 6.5 mmol/l and/
Table 5.1 Methods of physical examination
Outcome Method Cut-off score
Central obesity Waist to hip ratio (WHR): 
measurement of waist 
circumference and hip 
circumference
WHR ≥ 0.90 was classified as overweight 
and ≥ 1.00 as obese for men, and WHR  
≥ 0.80 was classified as overweight and 
≥ 0.88 as obese for women [58, 68].
Body fat percentage Skinfold measurement 
of the triceps, biceps, 
subscapular and 
suprailiacal
The sum of four skinfolds was used to 
calculate body density using the Visser 
equation [59]. Body fat percentage was 
calculated from body density using Siri’s 
equation [60].
Hypertension Blood pressure 
measurement
Systolic blood pressure ≥ 140 mmHg 
and/or a diastolic blood pressure ≥ 90 
mmHg [78] and/ or the use of blood 
pressure lowering drugs [88].
Peripheral arterial disease 
(atherosclerosis distal from 
the aortic bifurcation)
Ankle-brachial index 
measurement
Ankle-brachial index < 0.9 [120].
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or the use of lipid lowering drugs. Metabolic syndrome was defined using the criteria of 
the joint interim statement 2009 [67]. Metabolic syndrome was present if at least three 
of the following five criteria were met: a serum fasting glucose ≥ 5.6 mmol/l and/or the 
use of glucose lowering drugs, serum fasting triglycerids ≥ 1.7 mmol/l and/or the use 
of lipid lowering drugs, serum fasting HDL cholesterol ≤ 1.0 in men and ≤ 1.3 mmol/l 
in women and/or the use of lipid lowering drugs, and waist circumference ≥ 94 cm in 
men and ≥ 80 cm in women (reference values for overweight in Europeans, as this is a 
European Caucasian sample).
5.2.4 Statistical analysis
All analyses were done with the Statistical Package for the Social Sciences 17.0. First, 
non-response analyses were done using a t-test for age and chi-square-tests for gender 
and residential setting. Univariate associations between depression and anxiety and 
cardiovascular risk factors were performed using Pearson’s point-biserial correlation 
coefficient. Those cardiovascular risk factors that correlated significantly, or with a trend 
towards significance (p = 0.05), with depression or anxiety were subsequently entered in 
a multivariate logistic regression analysis, together with age, gender, level of ID, Down 
syndrome and anxiety or depression respectively (because of overlapping symptoms). 
Associations were checked for possible multicollinearity using the variance inflation 
factor (VIF) of linear regression analysis.
5.2.5 ethics
Ethical clearance has been provided by the Medical Ethics Committee of the Erasmus 
Medical Center Rotterdam (MEC 2008-234) and by the ethics committees of the 
participating care providing organizations. The study adheres to the Declaration of 
Helsinki for research involving human subjects [56].
5.3 ReSuLTS
The screening questionnaires for anxiety and depression were completed for 990 
participants with a mean age of 61.1 years (SD = 8.2). Of the sample, 48.7% were females. 
The majority (54.1%) lived on a central location of the care-providing organizations 
(in a sheltered environment with surrounding health facilities (e.g. physician, dentist, 
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movement therapy centre), whereas 40.7% lived in an accommodation in the community 
and 5.1% lived with their family or independently. Non-participants (n = 1332) and 
participants were not significantly different with respect to age (t = 0.27, p = 0.79), but 
men (chi-square = 4.72, p < 0.05) and people living independently (chi-square = 44.22, 
p < 0.05) were slightly underrepresented in the sample. Because not all participants 
completed all assessments from physical examination and vena-puncture, associations 
were computed for those available. Characteristics of the study population are shown 
in Table 5.2. Of the 990 participants, 16.8% had symptoms of depression and 16.3% had 
symptoms of anxiety. Diabetes was present in 97 people (13.8%), 9 had type I diabetes, 
Table 5.2 Characteristics of the study population (n = 990)
n %
Gender
Male 508 51.3
Female 482 48.7
Level of ID
Borderline (IQ = 70-84) 31 3.1
Mild (IQ = 50-69) 211 21.3
Moderate (IQ = 35-49) 471 47.6
Severe (IQ = 20-34) 165 16.7
Profound (IQ < 20) 89 9.0
Unknown 23 2.3
Residential setting
Central location 536 54.1
Community home 403 40.7
Living with family 7 0.7
Independent living 44 4.4
Symptoms of depression 166 16.8
Symptoms of anxiety 161 16.3
Smoking (n = 974) 194 19.6
Alcohol misuse (≥ 5 glasses/day) (n = 988) 3 0.3
Central obesity (waist to hip ratio) (n = 796) 385 48.4
Hypertension (n = 780) 412 52.8
Hypercholesterolemia (n = 702) 162 23.1
Diabetes (n = 702) 97 13.8
Metabolic syndrome (n = 568) 254 44.7
Peripheral arterial disease (n = 601) 127 21.1
Use of atypical antipsychotic drugs (n = 870) 55 6.3
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the others type II. metabolic syndrome, central obesity, hypercholesterolemia and 
hypertension in 44.7%, 48.4%, 23.1% and 52.8% respectively. 19.6% of the sample smoked 
and 21.1% had peripheral arterial disease. Atypical antipsychotic drugs were used by 
6.3% of the participants. Additional information on aetiology of ID and comorbidity of 
the study population is shown in Table 5.3.
Table 5.3 Information on aetiology of ID and co-morbidity and polypharmacy (n = 1050)
n %
Aetiology (n = 927)
No diagnosis of a genetic syndrome 653 70.7
Down syndrome 150 16.2
Fragile-X syndrome 9 1.0
Prader-Willi syndrome 1 .1
Rett syndrome 2 .2
Angelman syndrome 3 .3
Other genetic syndrome 58 6.3
Unknown 48 5.2
Autism (n = 1032) 178 17.2
Immobility (in a wheelchair) (n = 989) 107 10.8
Visual impairment (n = 924) 203 22.0
Hearing impairment (n = 924) 410 44.2
Epilepsy (n = 924) 196 21.2
Hypothyroidism (n = 924) 134 14.5
Hyperthyroidism (n = 924) 11 1.2
History of alcohol and/or substance misuse (n = 988) 26 2.6
Polypharmacy (≥ 4 types of medication) (n = 924) 487 52.7
There was no multicollinearity; all VIFs were between 1.01 and 1.92. In addition, 
relationships between the use of atypical antipsychotics and CVD risk factors was 
explored using Pearson’s point biserial correlation coefficient. There were no significant 
correlations between the use of atypical antipsychotics and central obesity (Pearson = 
.04, p = 0.24), body fat percentage (Pearson = -.005, p = 0.90), diabetes (Pearson = .01, 
p = 0.67), hypercholesterolemia (Pearson = .07, p = 0.08), hypertension (Pearson = .03, 
p = 0.49) and the metabolic syndrome (Pearson = .01, p = 0.80). Therefore, the use of atypical 
antipsychotics was not entered into the multivariate analyses as a possible confounder.
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5.3.1 Associations between depression and cardiovascular risk factors
Univariate associations between depression and cardiovascular risk factors are shown 
in Table 5.4. There were no significant correlations, only a trend towards significance 
for the correlation between crp and depression (p = 0.05). In the multivariate logistic 
regression analysis, people with Down syndrome were almost three times more likely to 
have depressive symptoms. Older people’s likelihood of depressive symptoms was only 
slightly (but significantly) elevated compared to younger people. Anxious people were 
ten times more likely to be depressive than people without anxiety symptoms (Table 5.5). 
The explaining value of this model is calculated with R², as the percentage of variance 
explained by the model. R² of the present depression model is 0.21, indicating a moderate 
amount of explained variance.
5.3.2 Associations between anxiety and cardiovascular risk factors
Univariate associations between anxiety and cardiovascular risk factors are shown in 
Table 5.4. There were significant correlations for anxiety and smoking, central obesity 
(by waist to hip ratio), body fat percentage, hypercholesterolemia and diabetes. In the 
multivariate logistic regression analysis, people with mild ID were almost four times 
more likely, and people with moderate ID almost three times more likely to experience 
anxiety symptoms, as compared to people with severe and profound ID. People with 
symptoms of depression were ten times more likely to also experience anxiety symptoms, 
than people without depressive symptoms. People with diabetes were almost two and 
a half times more likely to experience anxiety symptoms than people without diabetes 
Table 5.5 Odds ratios (OR) from a multiple logistic regression analysis with symptoms of 
depression as a dependent variable (n = 626)
OR 95% confidence interval p-value
Gender 1.07 .67-1.71 0.77
Mild ID .59 .28-1.23 0.16
Moderate ID .96 .55-1.67 0.88
Down syndrome 2.93 1.59-5.41 0.001
Age 1.03 1.00-1.06 0.03
Anxiety 10.19 5.87-17.70 0.000
C-reactive protein 1.01 .99-1.02 0.37
R² = .21.
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(Table 5.6). R² of the anxiety model is 0.27, which is a moderate amount of explained 
variance.
5.4 dISCuSSIon
This is the first study into the associations between depression, anxiety and cardiovascular 
risk factors in older people with ID. There was a significant association between increased 
anxiety symptoms and diabetes. No other associations with CVD risk factors could be 
proven to be significant. This study contributes to the yet very small body of knowledge 
on the interactions between psychosocial variables and physical illness indicators—more 
specifically: risk factors for cardiovascular disease—in people with ID. These findings may 
give rise to formulating recommendations for the improvement of clinical practice for 
older people with ID, and management (possibly prevention) of conditions that account 
for excess economic costs.
People with diabetes may encounter a lot of stress and medical visits in their lives. By 
frequent finger pricking, blood sugars are monitored, and regular vena-puncture is part 
of the health screening of people with diabetes. These measures may be frightening, 
especially for (older) people with ID. Also, complications of diabetes and hospitalizations 
may cause a lot of stress leading to anxiety. A disturbed glucose homeostasis, elevated 
Table 5.6 Odds ratios (OR) from a multiple logistic regression analysis with anxiety symptoms 
as a dependent variable (n = 524)
OR 95% confidence interval p-value
Gender 1.03 .56-1.91 0.92
Mild ID 3.82** 1.48-9.88 0.006
Moderate ID 2.67* 1.11-6.47 0.03
Age 1.00 .96-1.04 0.96
Down syndrome .36 .11-1.21 0.10
Depression 10.35*** 5.42-19.75 0.000
Smoking 1.60 .84-3.03 0.15
WHR obesity 1.49 .80-2.78 0.21
Diabetes 2.42* 1.19-4.90 0.01
Hypercholesterolemia 1.57 .83-2.95 0.16
R² = .27.
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inflammatory cytokines (which are likely in the case of diabetic complications) and 
vascular damage may give rise to symptoms of anxiety too [44, 47]. Because of its neuro-
endocrine effects (dysregulation of the hypothalamic-pituitary-adrenal cortex axis), 
anxiety might also contribute to an impaired glucose tolerance [44].
Other relations between anxiety and cardiovascular risk factors could not be proven 
in the multivariate analysis. Smoking, central obesity, a high body fat percentage and 
hypercholesterolemia were all significantly correlated to anxiety univariately, but these 
relations disappeared if they were entered in the multivariate analysis. This may be due 
to the fact that these are all related to a more mild level of ID (as does anxiety) [68, 88, 
96], and this may be the mediator in the association.
No correlations between depression and cardiovascular risk factors were found. The lack 
of correlation between depression and obesity confirms the findings of the earlier study 
in adults with ID [102]. Several explanations for the absence of associations may come 
to mind. The first is that we screened for increased depressive symptoms. Correlations 
might have been stronger in case of a diagnosis of major depression. Furthermore, one 
of the suggested mechanisms is that people worry about their cardiovascular risks, 
causing a depressed mood [46, 47]. People with ID might worry less about long-term 
consequences of their cardiovascular risks and may even lack the cognitive ability to 
understand their health risks.
The lacking correlation between depression and biological factors also raises the question 
whether depression is the same state of body and mind in people with ID as in the general 
population. Whereas in the general population depression and stress induce a cascade of 
hormonal changes, resulting in CVD (risk factors), this could not be proven in our study 
population of older people with ID. Do depressive symptoms in older people cause the 
same stress cascade in the brain as in the general population? Or are depressive symptoms 
an expression of a different process?
Strengths of the present study were that both psychological factors and cardiovascular 
risk factors were actually measured in a large sample and were not derived from file 
data. Moreover all somatic factors were objectively measured and not obtained using 
questionnaires as in the only previous study in adults with ID [102].
Weaknesses of the study were that information of those participants who were incapable 
of self-report, is based on information by proxy, which possibly makes associations 
more difficult to detect. Although the used instruments are valid for this population 
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[96], measurements by proxy always (slightly) differ from subjective measurements, 
depending on how subjective the investigated concept is. Moreover we used screening 
tools for symptoms of depression and anxiety. For a small proportion of the participants 
diagnostic interviews were available, but statistical power was too small to use these for 
the analyses. People with ID may express these symptoms not only when they have a true 
depression or anxiety disorder (as defined in the ICD-10), but also when they experience 
pain, discomfort or distress from other physical or social conditions [121], which could 
be possible confounders of the relationship we studied. Furthermore, we did not control 
for dementia which has some similar symptoms as depression which is also reflected 
in the higher proportion of people with Down syndrome and depressive symptoms (as 
dementia is highly prevalent in older people with Down syndrome). Not all participants 
completed all physical assessments, which increases the threat of selection bias. However 
the analyses showed that selection bias was only mild.
In future prospective studies the causal relationship between mood disorders as well 
as cardiovascular risk factors and cardiovascular disease could be elucidated. Cortisol 
levels should be measured to unravel the mechanism of stress, depression and biological 
consequences in older people with ID.
The main contribution to the field of this article is the establishment of the association 
between anxiety and diabetes. This finding suggests a potential importance of screening 
for anxiety in older people with ID and diabetes. This might become part of the standard 
health watch for diabetes in people with ID. Moreover people with ID and anxiety or mood 
disorders should be screened for diabetes and components of the metabolic syndrome 
[122]. Thus, prevention measures can be taken for those who present with diabetes or 
pre-diabetes (defined by impaired fasting glucose and/or impaired glucose tolerance), as 
recommended by the International Diabetes Federation [123]. Screening is necessary to 
provide comprehensive care for people with ID who are at risk of depressive or anxiety 
disorders and cardiovascular disease.
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ABSTRACT
With increasing longevity and cardiovascular events, chronic kidney disease may also 
become a significant problem in older people with intellectual disability (ID). We 
studied prevalence and associations of chronic kidney disease as part of the Healthy 
Ageing and Intellectual Disability (HA-ID) study, a large Dutch cross-sectional 
study among people with ID aged 50 years and over, using creatinine and cystatin-C 
measurement in plasma. Glomerular filtration rate (GFR) was calculated using 
the Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease 
Epidemiology Collaboration (CKD-EPI) equations. Equations based on creatinine 
(as the MDRD equation) may underestimate kidney dysfunction in people with 
sarcopenia, because low muscle mass leads to a low creatinine production. Therefore, 
also prevalence of chronic kidney disease was studied in the sarcopenic group, 
using different GFR equations. Prevalence of chronic kidney disease, among 635 
participants, was 15.3%, which equals prevalence in the general Dutch population. 
In the group of participants with sarcopenia (n=82), the CKD-EPI equation based on 
creatinine and cystatin-C gave a higher prevalence of chronic kidney disease than did 
the MDRD equation, but confidence intervals were very wide. Chronic kidney disease 
was associated with higher age, Down syndrome, obesity, hypercholesterolemia and 
hypothyroid disease.
GFR should be measured in all older people with ID and polypharmacy, and in older 
people with ID and Down syndrome as part of the regular health checks. Moreover, 
if sarcopenia is present and information on GFR is required, this should not be 
measured based on creatinine only, but additional measures, such as cystatin-C, 
should be taken into account.
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6.1 InTRoduCTIon 
Chronic kidney disease is a major health problem, especially in older people and in 
people with cardiovascular disease, diabetes or hypertension. It can proceed into kidney 
failure and also contributes to increased morbidity and mortality from cardiovascular 
disease. As people with intellectual disability (ID) tend to get older, chronic diseases and 
polypharmacy become increasingly prevalent in this group. Eighty percent of people with 
ID aged 50 years and over have two or more chronic diseases [124], whereas 52% use 
four or more types of medication [125]. In these conditions renal functioning should be 
taken into account.
There are several reasons to suspect that people with ID are at risk of renal dysfunction. 
Some genetic syndromes are associated with renal dysfunction. In a study among 
66 children with Down syndrome, eight percent had congenital kidney disease or 
glomerulopathy. Of these children, 4.5% had renal failure [126]. In another study among 
103 persons with Down syndrome aged 1-57 years, a significantly lower excretion of 
creatinine in urine was found as compared to non-ID controls. The authors suggest 
that this might be due to oxidative stress, which also leads to premature aging in Down 
syndrome [127, 128]. Some more rare genetic syndromes are associated with congenital 
kidney diseases. Renal anomalies are present in 46% of people with Bardet-Biedl 
syndrome, mostly hyperechoic kidneys and cystic dysplasia. Many people with this 
syndrome (70%) develop chronic renal failure and 10-30% require kidney replacement 
therapy. People with Lowe syndrome have a specific tubulopathy. In Joubert syndrome 
people have, depending on the genetic mutation, nephronophtisis (chronic tubule-
interstitial nephritis) [129]. In Williams syndrome, renal anomalies may occur, such as 
hypoplastic kidneys and renal artery stenosis [130].
In a large Taiwanese study among adolescents with ID by heterogeneous causes a 
significantly increased prevalence of renal dysfunction was found [48]. Information about 
patient characteristics was limited, which reduces insight into possible selection bias or 
other underlying mechanisms for an increased risk on renal dysfunction. Although the 
authors did not mention sarcopenia (low muscle mass), which results in underestimation 
of renal dysfunction with the used diagnostic methods, the significantly lower prevalence 
in the subgroup with underweight points in this direction, and suggests that the prevalence 
published in this study was an underestimation of the actual amount of renal dysfunction 
in this group.
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Risk factors for renal damage are (as they are in the general population) the presence of 
diabetes, hypertension, smoking and use of lithium. These risk factors were studied in the 
Healthy Ageing and Intellectual Disability (HA-ID) study, a large Dutch cross-sectional 
study into health of people with ID aged 50 years and over. There is an increased risk 
on the development of diabetes, whereas hypertension and smoking occur as frequently 
as in the general population [88]. Peripheral arterial disease (atherosclerosis distal from 
the aortic bifurcation) indicates atherosclerosis and thus is a risk for microvascular renal 
damage. The increased risk on diabetes is probably due to metabolic changes based on 
muscular inactivity in people with an impaired mobility and in the large group with a 
sedentary lifestyle [32], and to the widespread use of antipsychotic drugs [35]. We have 
recently shown that also the risk on peripheral arterial disease is increased as compared 
to the general population [120]. Moreover renal functioning is directly influenced by 
thyroid hormones, as these induce glomerular filtration [131]. Hypothyroid disease is 
also a significant problem in people with ID [132]. These are reasons to expect that renal 
dysfunction can be a relevant problem in older people with ID.
Sarcopenia (loss of muscle mass) is highly prevalent (14%) in older people with ID [95].It is 
unknown if sarcopenia occurs more often than in the general population, but the presence 
of motor disabilities from early age on in addition to the age-related motor problems 
support this hypothesis [95]. The, inherent to sarcopenia, low creatinine production can 
lead to underestimation of renal dysfunction. This means that creatinine measurement, 
although it is the most widely used technique, may not be the most reliable indicator of 
renal damage. Cystatin-C is a protease inhibitor produced by nearly all cells in the body. 
This protein is, after filtration by the glomerulus, metabolised in the proximal tubular 
epithelial cells. It may be a good indicator for renal dysfunction in older people, as it is 
not influenced by the muscle metabolism [133]. Both creatinine and cystatin-C can be 
used to calculate the estimated glomerular filtration rate (eGFR), the measure for kidney 
functioning. Most widely used in clinical practice is the Modification of Diet in Renal 
Disease (MDRD) study equation for calculating the eGFR [134]. However, this equation is 
not reliable for the normal range of GFR and tends to over-estimate kidney disease, which 
is why a new equation to predict GFR, based on serum creatinine, was developed by the 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI creatinine equation) 
[135]. This equation more accurately classified people into GFR categories than did the 
MDRD [136]. Because of the better performance in people with low muscle mass, GFR 
estimating formulas have also been designed based on cystatin-C (CKD-EPI cystatin C 
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equation), but the most reliable estimation is based on both creatinine and cystatin-C 
(CKD-EPI creatinine-cystatin-C equation) [137].
To our knowledge, there has been no research into renal dysfunction in older people with 
ID. Therefore, the aims of the present study were:
1. To determine the prevalence of chronic kidney disease in older people with ID
2. To determine the prevalence of chronic kidney disease in the sarcopenic group based 
on different GFR equations (MDRD and CKD-EPI using creatinine and cystatin-C 
measurement).
3. To identify correlates of renal dysfunction in older people with ID (gender, age, level of 
ID, mobility, Down syndrome, diabetes, hypertension, obesity, hypercholesterolemia, 
smoking, peripheral arterial disease, use of antipsychotic drugs, sarcopenia, 
hypothyroid disease).
6.2 MeThodS 
6.2.1 design
This study is part of the large cross-sectional HA-ID study [5]. Three care-providing 
organisations in the Netherlands participated in the study. These organisations offer low 
to high level specialised support and care to people with ID. Ethical approval has been 
provided by the Medical Ethics Committee of the Erasmus Medical Center Rotterdam 
(MEC 2008-234) and by the ethics committees of the participating care-providing 
organisations. The study adheres to the Declaration of Helsinki for research involving 
human subjects [56].
6.2.2 Participants
A full description of details about design, recruitment and representativeness of the sample, 
as well as diagnostic methods, has been published elsewhere [5]. Of the three participating 
organisations, 2150 clients aged 50 years and over were invited to participate. Informed 
consent was provided by 1069 clients or their legal representatives, of whom 1050 clients 
participated in the assessments. This study population was almost representative for the 
total Dutch older ID population receiving formal care or support: only people living 
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independently and people aged 80 years and over were underrepresented, women were 
slightly overrepresented [5]. Only those 637 participants of the total HA-ID population who 
had participated in vena-puncture and from whom remained enough material for the present 
analysis could be included in the present study. There were no other exclusion criteria.
Although all participants (clients or their representatives) had given their consent for 
storage and further analyses from frozen plasma, a second round of informed consent was 
asked for new analyses from frozen plasma, for which two participants denied consent, 
which finally resulted in 635 participants in this study. 
6.2.3 data collection
Gender and age were collected from the records of the care-providing organisations. 
Participant characteristics were obtained from medical files. Behavioural therapists and 
psychologists completed checklists with the level of ID from their files (borderline, mild, 
moderate, severe, profound). General practitioners and specialized physicians for people 
with ID recorded etiology (Down syndrome yes /no), presence of thyroid disease and use of 
medication. Smoking was reported by a personal caretaker. Obesity (by body mass index) 
[68], hypertension, hypercholesterolemia, diabetes [88], peripheral arterial disease [120], 
mobility [53] and sarcopenia [95] were part of the physical and laboratory assessments. 
Sarcopenia was measured using muscle mass by calf circumference, muscle strength by 
grip strength and muscle performance by comfortable walking speed. Sarcopenia was 
defined as having low muscle mass combined with low muscle strength and/or low muscle 
performance [95]. Peripheral arterial disease was measured using the ankle-brachial 
index, using a cut off score < 0.9 for the diagnosis. Participants underwent venapuncture 
by specially trained medical assistants after an overnight fast between November 2008 
and July 2010. If people showed any kind of (unusual) resistance, measurements were 
stopped. Serum was transported frozen and stored at -80 degrees Celsius at the Erasmus 
Medical Center. Participants of whom no serum had been obtained were excluded from 
this study. Blood samples were analysed in June 2013 at the laboratory of the Erasmus 
Medical Center. Creatinine and cystatin-C were measured using the Cobas 8000 Modular 
Analyzer from Roche Diagnostics AG (Rotkreuz, Swiss). GFR was calculated using the 
MDRD study equation [134], the CKD-EPI creatinine equation [135], the CKD-EPI 
cystatin-C equation and the CKD-EPI creatinine-cystatin-C equation [137]. A GFR < 
60 ml/min/1.73m² was considered as chronic kidney disease (CKD), as recommended 
by the National Kidney Foundation [138].
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6.2.4 Statistical analysis
Data were analysed using IBM SPSS Statistics 17.0. Descriptive statistics are provided 
for gender, age, aetiology and level of ID. With chi-square analysis we tested if there 
were any differences between the present study participants and the total HA-ID study 
population in gender, age (age groups 50-59, 60-69, 70-79, 80-89, 90+) and level of ID 
Descriptive statistics were used to report prevalence rates of CKD based on the four GFR-
equations for both the total study population (aim 1) and the sarcopenic subgroup (aim 
2). To explore associations (aim 3) univariate logistic regression analyses were performed 
between chronic kidney disease (dependent variable), based on GFR as calculated by the 
CKD-EPI creatinine-cystatin-C equation, and participant characteristics (correlates); 
gender, age, level of ID, diagnosis of Down syndrome, mobility, diabetes, hypertension, 
hypercholesterolemia, body mass index (categorised as normal, overweight or obesity), 
smoking, peripheral arterial disease, use of atypical antipsychotic drugs, hypothyroid 
disease and sarcopenia (independent variables). If an independent variable showed a 
significant association (p < 0.05) with the dependent variable, it was subsequently entered 
into a multivariate logistic regression analysis. People with missing data on any of the 
variables were excluded from the logistic regression analysis. Odds Ratios (OR) were 
provided for those variables included in the logistic regression analysis. Associations 
were checked for possible multicollinearity using the variance inflation factor (VIF) of 
linear regression analysis.
6.3 ReSuLTS
For analysis of kidney functioning, serum was available from 635 out of 1050 HA-ID 
participants. Participant characteristics are presented in Table 6.1. As compared to the 
total HA-ID population, men were slightly overrepresented (chi-square 4.9, p = .02). 
Age and level of ID-groups were similarly represented as in the total HA-ID population.
6.3.1 Prevalence of chronic kidney disease
Prevalence of CKD in the total study population according to the different equations 
are shown in Table 6.2. Eighty-two participants met the criteria for sarcopenia [95]. 
Prevalence of CKD in this subgroup, according to the different equations (aim 2), is also 
shown in Table 6.2.
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6.3.2 Associations of chronic kidney disease
Results of the univariate and multivariate analyses are presented in Table 6.3. Independent 
variables included in the multivariate logistic regression model were gender, age, 
mobility, Down syndrome, hypercholesterolemia, obesity, peripheral arterial disease and 
hypothyroid disease (Table 6.3). There were 398 participants included in the multivariate 
logistic regression model, after excluding participants with missing values on any of the 
independent variables. The proportion explained variance of the model (R²) was 0.27. 
There was no multicollinearity; all VIFs were between 1.02 and 1.29. Groups that were 
significantly more at risk of CKD, were people with higher age (OR 2.38 for each ten 
Table 6.1 Participant characteristics
n %
Gender (n=635) Male 343 54.0%
Female 292 46.0%
Aetiology (n=570) Down 88 15.4%
Level of ID (n=629) Borderline ID 13 2.1%
Mild ID 132 21.1%
Moderate ID 321 51.2%
Severe ID 102 16.3%
Profound ID 59 9.4%
Age (n=635) Mean 61.7 years Range 50-92 SD 8.1
Serum creatinine (n=635) Mean 75.19 Range 31-219 SD 19.91
Serum cystatin-C (n=635) Mean 1.05 Range .41-2.46 SD .26
SD = standard deviation.
Table 6.2 Prevalence of chronic kidney disease
Equation Number of 
CKD in the 
total study 
population 
(n=635)
% CKD in 
total study 
population
95% CI % in the 
sarcopenic 
group 
(n=82)
95% CI 
in the 
sarcopenic 
group
MDRD 68 10.7% 8.3-13.1 4.9% 0.2-9.5
CKD-EPI creatinine equation 48 7.6% 5.5-9.6 3.7% 0-7.7
CKD-EPI cystatin-C equation 171 26.9% 23.5-30.4 30.5% 20.5-40.5
CKD-EPI creatinine-cystatin-C 
equation
97 15.3% 12.5-18.1 12.2% 5.1-19.3
CI = confidence interval.
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year category), Down syndrome (OR 6.86), hypercholesterolemia (OR 2.65), obesity (OR 
1.74) and hypothyroid disease (OR 3.14). From 88 participants with Down syndrome, 
33.0% (95% CI 23.1 - 42.8) met the criteria for CKD disease according to the CKD-EPI-
creatinine-cystatin-C equation.
6.4 dISCuSSIon
This study is, until now, the only internationally published epidemiologic study into renal 
dysfunction in older people with ID. We found a prevalence of 15.3% (95% CI 12.5 - 18.1) 
of CKD using the CKD-EPI creatinine-cystatin-C equation. Unfortunately, no published 
epidemiological studies in the general population, using this equation, were available for 
comparison. Using the MDRD equation (10.7%, 95% CI 8.3 - 13.1) the prevalence of CKD 
is the same as in the general same aged Dutch population (12.2%, 95% CI 11.4 - 13.5) 
[139]. In participants with sarcopenia, the lower prevalence as established with the MDRD 
Table 6.3 Logistic regression analysis of chronic kidney disease by CKD-EPI creatinine-
cystatin-C equation
Univariate 
analyses
Multivariate analysis 
Odds Ratio (n=398)
95% CI
Gender (n=635) 1.9** .95 .48-1.87
Age (10 year categories) (n=635) 1.9*** 2.38*** 1.58-3.58
Level of ID (n=627) -
Mobility (n=616) 1.3* .89 .50-1.59
Down syndrome (n=570) 3.4*** 6.86*** 2.70-17.40
Diabetes (n=635) -
Hypertension (n=539) -
Hypercholesterolemia (n=635) 1.7* 2.65** 1.33-5.29
Obesity (body mass index categories) (n=566) 1.7*** 1.74** 1.15-2.64
Smoking (n=611) -
Peripheral arterial disease (n=488) 1.9* 1.89 .96-3.70
Use of atypical antipsychotic drugs (n=572) -
Hypothyroid disease (n=561) 4.3*** 3.14** 1.43-6.90
Hyperthyroid disease (n=558) -
Sarcopenia (n=565) -
* p < .05, ** p < .01, *** p < .001.
- = no significant correlation; CI = confidence interval.
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equation than that established with the CKD-EPI creatinine-cystatin-C equation, suggests 
an underestimation of the prevalence of CKD using the routine formula. As was to be 
expected, and comparable to the distribution in the general population, CKD was associated 
with higher age [140], hypercholesterolemia [141], obesity [142] and hypothyroid disease 
[131]. Down syndrome gave an almost seven times increased risk on CKD, which was the 
only association specific for the ID population. There was no difference in prevalence of 
CKD between men and women. In a large epidemiological study in the general population, 
stage 5 CKD (eGFR < 15 ml/min/1.73 m²) was significantly more prevalent in men in 
the group without diabetes, and stage 3 CKD (eGFR 30 - 59 ml/min/1.73 m²) was more 
prevalent in women irrespective of the presence of diabetes [140]. Prevalence figures were 
not comparable to our study data due to differences in study design and methods. The 
proportion explained variance of our regression model was not high (R² = 0.27), which 
means that there are more (unstudied) associated factors explaining the population risk.
As could be expected CKD was independently associated with correlates of atherosclerosis. 
Many of these cardiovascular risk factors remain undiagnosed in people with ID: 45-50% 
of cases with hypertension, diabetes and hypercholesterolemia [88] and 97% of cases with 
peripheral arterial disease [120] had not been previously diagnosed with these conditions 
in our study into these conditions. People with ID are not always capable of or supported 
in addressing their symptoms, asking questions about their health, or being aware of long 
term health consequences. This warrants concern for renal dysfunction in this group. 
If cardiovascular risk factors or diseases are overlooked, this may as well occur with 
(beginning) renal dysfunction, especially when cardiovascular risk management (which 
includes screening for kidney disease) is not performed. Therefore, chronic kidney disease 
may proceed into more advanced stages before it is detected.
Down syndrome was highly associated with CKD, independent of hypothyroid disease, 
and even though they are at lower risk of atherosclerosis [143] and (components of) the 
metabolic syndrome [88]. Although there were some indications, mostly from smaller 
studies in children and adolescents [127], for renal dysfunction, these were mostly based 
on congenital disorders, as established with GFR and renal ultrasound. This is the first 
time that an increased risk on chronic kidney disease in older people with Down syndrome 
has been shown. This leaves questions in regard to the underlying pathophysiology. One 
theory could be that free radicals and increased oxidative stress [127, 128], as a result of 
an impaired DNA-repair system [144], or the recently discovered impaired somatic stem 
cells (tissue resident cells that self renew throughout life to repair damaged cells) [145], 
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could directly damage the kidneys as part of premature aging. Another theory would 
be that increased circulating proteins in plasma, such as β-amyloid, which is deposited 
extracellular and plays a crucial role in the development of Alzheimer dementia, could 
lead to microvascular damage and reduced renal functioning. Such a mechanism would 
particularly affect people with Down syndrome, due to the triplication of chromosome 
21, leading to over expression of the amyloid precursor protein [146-148] and neopterin 
(a marker for cell-mediated immune activation and inflammation) [149, 150].
Limitations of the present study were that we did not use the gold standard for 
measuring GFR, the collection of 24-hours urine. This method is not feasible for 
larger epidemiological studies in this vulnerable group of participants. Also, additional 
information on kidney disease, through measurement of proteins in urine, was not 
available. Another limitation is that there were no comparison groups available in the 
literature, where GFR was studied using the CKD-EPI creatinine-cystatin-C equation. 
The group participants with sarcopenia was rather small, which makes it difficult to draw 
firm conclusions on GFR measurement in this group. However, conclusions are supported 
by current research, which implies that GFR estimations based on creatinine alone do 
not perform well, especially in groups with low muscle mass, and that the combined 
creatinine-cystatin-C equation may be useful as a confirmatory test [137]. Strengths of 
the present study are the innovative character in the population with ID, this major health 
issue has hardly ever been studies in this population. Furthermore, given the population, 
the sample size is large, and both creatinine and cystatin-C are used for calculating GFR.
Implications for clinical practice are that renal functioning measurement using the MDRD 
equation in older people with ID and sarcopenia is not reliable. If information on GFR is 
required in this group additional determinants should be measured, such as cystatin-C, 
or albumin in urine to gain more information on chronic kidney disease. Moreover, in 
patients with Down syndrome, kidney functioning should be measured, as part of the 
current healthwatch for people with Down syndrome. Also, in all older people with 
ID and polypharmacy kidney functioning should be measured. For future insight into 
the pathophysiology of chronic kidney disease in people with Down syndrome, more 
fundamental research is required. This study showed that chronic kidney disease is a 
significant problem in older people with ID and that there are several implications for 
monitoring renal functioning in this group, in order to detect renal functioning at early 
stage and to prevent it from proceeding into more severe forms of kidney disease and 
eventually kidney failure.
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The Healthy Ageing and Intellectual Disability (HA-ID) study aimed at gaining knowledge 
on healthy ageing by studying health and health risks in an older population of people with 
intellectual disabilities. In this thesis, an overview of cardiovascular disease risk factors is 
presented, covering prevalence, associations, resulting atherosclerosis and comorbidity. 
Thereby it contributes to the knowledge on one of the most prominent aging diseases 
of this time, cardiovascular disease, which will become increasingly prevalent in people 
with intellectual disabilities, given their improved longevity in the last decades.
Principal findings
We have established that some important cardiovascular disease risk factors, which are 
also a burden of disease by themselves: peripheral arterial disease, diabetes and obesity 
(in women), occur more often among aging people with intellectual disability than in 
the same aged general population. Other risk factors, hypertension, metabolic syndrome 
and obesity in men, occur as frequently as in the general population, which is a reason to 
worry, as cardiovascular risk factors in the general population also are a major problem. 
Chronic kidney disease, which may result from atherosclerosis of kidney vessels, occurs as 
frequently as in the general population. We were able to compare our data to the general 
population, because in the same period in which the HA-ID study was performed, the 
National Institute for Public Health conducted and published a comparable cross-sectional 
study on cardiovascular disease risk factors using identical outcome measures [81]. For 
peripheral arterial disease comparable data were available from the Dutch participants of 
the Pandora study [86], and for chronic kidney disease we could compare our data with 
those of a large representative epidemiologic study among older people, the Rotterdam 
study [139].
Associations and mechanisms
Within the intellectually disabled population, mostly people who live more independently, 
people with mild intellectual disability who are able to make their own choices on lifestyle, 
like doing groceries and cooking meals independently, are more at risk of developing 
obesity, hypertension, hypercholesterolemia, diabetes and the metabolic syndrome. This 
represents the lifestyle-related part of the risk factors, which can be a target for intervention 
programs, such as education and training programs for healthier diets, physical activity 
and smoking cessation. In the intellectually disabled population, these targets (diet, 
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physical activity and smoking) are even more important to address, as the HA-ID study 
also showed that physical inactivity and a sedentary lifestyle are very widespread problems 
among older people with intellectual disability [32]. Smoking occurs as much as in the 
same-aged general population (unpublished data from the HA-ID study).
The people with peripheral arterial disease represent a partly different subgroup of the 
population with intellectual disability. They are more dependent on others in daily life. 
This association may be bidirectional. Some of them have been functionally disabled and 
more dependent in daily activities from a younger age onwards. Inactivity contributes to 
the development of peripheral arterial disease. Later in life, the functional disability is 
possibly due to, or worsened by (multi-)morbidity, of which cardiovascular disease can 
be one of the causes.
There are several other possible mechanisms that can lead to a disturbed metabolic 
homeostasis, resulting in increased cardiovascular disease risk factors in the population 
with intellectual disability (Figure 7.1). First of all, there is the widespread use of 
psychotropic drugs [36], of which especially (but not only) the atypical antipsychotic 
agents cause obesity and the metabolic syndrome. In psychiatric patients this has 
Figure 7.1 Associated factors of the metabolic syndrome, that are all interrelated.
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been shown to lead to significantly increased cardiovascular mortality [38, 39]. In 
people with intellectual disability, atypical antipsychotics are usually used off-label for 
challenging behavior (such as aggression or self-injurious behavior) [35], and significant 
improvement of metabolic parameters has been shown when doses are lowered or when 
the antipsychotic drug is discontinued [40].
A second possible mechanism is the influence of a disturbed circadian rhythm on 
metabolic homeostasis. The HA-ID study showed that sleep-wake rhythm was less 
stable and more fragmented in older people with intellectual disability as compared to 
a control group from the general older population [151]. The suprachiasmatic nucleus 
paces sleep-wake rhythm as a reaction to daylight. It degenerates with aging, which is a 
cause of a disturbed sleep-wake rhythm in older people. A disturbed sleep-wake rhythm 
leads through different pathways to a disturbed glucose metabolism. The pituitary 
gland influences glucose metabolism, through cortisol, growth hormones and other 
regulatory hormones. The autonomic nervous system influences the production of 
insulin and thus glucose both directly and through the pancreatic-β cells, but influences 
also other cardiovascular risk factors. Finally the pineal gland affects glucose metabolism 
through the production of melatonin [152]. We know that melatonin production is often 
disturbed in people with intellectual disability [153, 154]. Moreover, in some cases, the 
brain alterations inherent to the cause of the intellectual disability may be additive to the 
natural degeneration of the suprachiasmatic nucleus, which could explain the increased 
circadian rhythm problems [151] and the resulting metabolic disturbances.
Linked to the extremely low levels of physical activity is the possibility of lack of daylight 
exposure and thus low levels of vitamin D. Although in some groups this is supplemented, 
many older people with intellectual disability have vitamin D deficiency [155]. Vitamin 
D is related to cardiovascular risk factors and cardiovascular disease on multiple levels. 
Obesity reduces serum vitamin D levels, by sequestrating vitamin D into adipose tissue. It 
can be released during weight loss. Correction of vitamin D deficiency may improve β-cell 
functioning, and reduce inflammation mediated β-cell apoptosis, in insulin resistance 
[156]. Vitamin D may be associated with serum lipid levels and the metabolic syndrome 
independent of weight status [156, 157]. Moreover vitamin D suppletion may improve 
type II diabetes and the outcome of cardiovascular disease, but confounding factors, such 
as physical inactivity, make this relationship unsure [156].
Another mechanism linked to the low levels of physical activity is the metabolic effect 
of inactivity of the large muscles. The large (leg) muscles metabolize body glucose. With 
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a sedentary lifestyle, this counts for a dysfunctioning metabolizing organ and thereby it 
contributes to the development of diabetes [33].
Another possible cause of cardiovascular disease risks are the high amount of anxiety and 
mood disorders and stress resulting from frequent life-events among older people with 
intellectual disabilities [96, 158]. These conditions mutually affect each other through 
lifestyle, inflammatory and neuro-endocrine changes (the hypothalamic-pituitary-adrenal 
cortex axis and sympathetic nervous system activation). The association between anxiety 
and diabetes was confirmed in this thesis.
Chronic inflammation is a key feature of obesity, type II diabetes and the metabolic 
syndrome. In obesity, inflammatory cytokines are more expressed, and adipocytes are 
infiltrated by macrophages. Inflammatory cytokines cause disruption of insulin action and 
mediate insulin resistance at the enzyme, activator and receptor level, thus blocking the 
signaling pathways [159]. As a result to stress (which can be nutrient excess or deficiency, 
inflammation, infection or hypoxia) peptide mediated pathways (inflammatory cytokines, 
chemokines and receptors) or lipid mediated pathways (lipids, fatty acids, metabolic 
enzymes and receptors) can be induced, which both lead to activation of signaling cascades 
and then to metabolic disease clusters [159]. Older people with intellectual disability 
have been shown to be at risk of several conditions in which chronic inflammation play 
a crucial role. Multimorbidity [124], sarcopenia [95] (or obesity sarcopenia [160]) and 
frailty [94, 161] are frequently encountered health problems in the intellectual disabled 
population, associated with an increased inflammatory state [162].
Frailty is a geriatric syndrome associated with high vulnerability for adverse health outcomes. 
Both the phenotype (slow walking speed, impaired grip strength, low activity levels, 
unintended weight loss and exhaustion) and the multifactorial definition (a combination of 
signs and symptoms of chronic physical conditions, social circumstances and mental health) 
are applicable to the population of older people with intellectual disability [94, 161, 163]. In 
the HA-ID study it has been shown that people with intellectual disability aged 50 years and 
over had frailty index scores comparable to older people from the general population aged 
75 years and over [161]. Cardiovascular disease risks and the metabolic syndrome may have 
common underlying mechanisms and may also contribute to (the progression of) frailty. 
Several components, such as obesity, hypertension, diabetes, peripheral arterial disease and 
cardiovascular disease are included in the frailty index for older people with intellectual 
disability as contributing deficits to the concept of frailty [161]. Not only are they disabling 
conditions and general health threats, the hypothesized common underlying pathways 
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may play a crucial role in the development of frailty. A poor nutritional state (through 
the development of (obesity-)sarcopenia, loss of muscle mass accompanied by increased 
fat mass), inflammatory pathway dysregulation (as measured by increased inflammatory 
markers such as c-reactive protein, interleukin-6 and tumor necrosis factor α), endocrine 
dysregulation (low insulin-like growth factor 1, which is associated with frailty and insulin 
resistance), hematocoagulation system activation (in frailty research, D-dimer, factor VIII 
and fibrinogen are studied as biomarkers, which are also studied as newer risk markers for 
cardiovascular disease [139]) and insulin resistance in itself (both by hyperglycemia and 
by increase in adipose tissue mass and loss of lean mass) all cause or increase frailty [164].
Cardiovascular disease
The significant amount of cardiovascular disease risk factors leads to an increased 
risk of peripheral atherosclerosis. However, the evidence on the effect of the risk 
factors on incidence of myocardial infarction and cerebrovascular accidents in people 
with intellectual disability remains scarce. Cardiovascular morbidity is insufficiently 
studied, as the only internationally published studies are two limited Dutch studies 
[8, 9]. Retrospectively studied, it has been suggested that prevalence and incidence of 
myocardial infarction and stroke in older people with intellectual disability do not differ 
from the general population. However, myocardial infarctions were underreported, which 
suggests that this diagnosis may be missed due to atypical presentation of symptoms and 
complaints [9]. This underdiagnosis may have led to an underestimation of the prevalence 
and incidence of cardiovascular disease in the group with intellectual disabilities. This 
resembles the underdiagnosis of cardiovascular disease risk factors and peripheral arterial 
disease that we found in this thesis. In two older studies on reported causes of death 
among people with intellectual disabilities, cardiovascular disease was a major cause of 
death [165, 166]. There was an increased risk of death due to (ischaemic) cardiovascular 
disease as compared to the general population, and, as was shown with the cardiovascular 
disease risk factors in this thesis, women were more at risk than men [166].
Recommendations for policy and practice
This study has shown that everyone who works with or for older people with intellectual 
disabilities should be well aware of the cardiovascular disease risk. An anticipating 
preventive policy should be embedded in the whole care for people with intellectual 
Chap7_Channa.indd   94 4-7-2014   15:46:42
95
G
eneral discussion
Chapter 7
disability, both by care providing organizations and by the municipality, which is 
responsible for the support of people with intellectual disability who need lower levels 
of care and support. This includes education on healthy lifestyle for personal care givers 
and for people with mild levels of intellectual disability. Furthermore, care providing 
organizations should incorporate targeted health promotion programs in daily care and 
activities. As part of the HA-ID study such a program has been started [167] and has 
proven to be effective on improving physical activity and health parameters. Further 
evidence-based interventions are now being designed within the HA-ID consortium. 
Only recently policy makers have started to recommend health promotion for this 
population. Chronic healthcare insurance companies (as supervised by the Dutch 
Healthcare Authority, NZa) now ask care providing organizations to design and justify 
their preventive health policy. This is a trend following the general population where 
preventive health campaigns have been conducted for many years now. People using 
formal care of some care providing organization may benefit from this policy. However, 
there are many people with mild or borderline intellectual disability who do not make 
use of any form of formal care or support from care organizations, and will not benefit 
from such interventions. Moreover, it is well-known that the lower the level of education, 
the lower the effect of large-scale preventive campaigns on change of behavior. This 
warrants concern for the group with borderline intellectual disability, as these are also 
the people who are most at risk for developing cardiovascular risks factors, according 
to findings of this study.
Currently, diagnosis and treatment of cardiovascular risk factors occurs according to the 
standard of the Dutch College of General Practitioners ‘Cardiovascular risk management’ 
[168]. A cardiovascular risk profile, including age, gender, smoking, family history, diet, 
use of alcohol, physical activity, blood pressure, body-mass index, serum lipids and 
glucose and estimated glomerular filtration rate, is composed for people with known 
cardiovascular disease, diabetes and rheumatoid arthritis. Treatment of risk factors 
is based on the subsequent 10-year risk of cardiovascular morbidity and mortality. A 
cardiovascular risk profile can also be composed for people asking for a risk assessment, 
or with a known positive family history, smoking or obesity. Moreover people with 
hypertension, hypercholesterolemia and chronic kidney disease should be screened for 
cardiovascular risk factors. The standard has not been designed for active and systematic 
detection of risk factors. A major problem with implementing cardiovascular risk 
management in this population is that people with intellectual disability generally do not 
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ask for risk assessment by themselves. As we know from this study, many cardiovascular 
risk factors remain undiagnosed, which leads to under treatment if the present standard 
is applied to this group, too. Prevention in people without present cardiovascular disease 
is more effective than prevention in people with manifest cardiovascular disease. For 
the active screening and detection of undiagnosed risk factors, the Dutch College of 
General Practitioners has designed the standard “Prevention Consult”, which consists 
of a questionnaire that patients are supposed to fill in themselves [169]. However, this 
questionnaire is not designed for people with intellectual disabilities and they are not 
included as a separate risk group [169]. Therefore, general practitioners and specialized 
physicians for people with intellectual disabilities (ID-physicians) should perform pro-
active cardiovascular risk management, starting before the client is aged 50 years. This 
includes screening for and treatment of cardiovascular risk factors, peripheral arterial 
disease and kidney dysfunction. Moreover, through medication reviews, atypical 
antipsychotics should be discontinued when there is no appropriate indication.
When the preventive stadium is passed, risk factors have proceeded into causing 
cardiovascular disease. Despite high quality medicine for people with intellectual 
disability, cardiovascular morbidity may remain underdiagnosed. Where cerebrovascular 
accidents are relatively easy to recognize through the physical symptoms, and are probably 
diagnosed adequately, angina pectoris, peripheral arterial disease and myocardial 
infarction may be missed [9]. These conditions should be considered in case of atypical 
signs, such as behavioral changes or delirium. Active treatment of cardiovascular disease 
should be considered. From clinical practice, it appears that invasive cardiac surgery (such 
as percutaneous coronary intervention and coronary artery bypass grafting) is rarely 
performed in this group [9], which leaves questions with regard to supposed feasibility 
of these treatments. Under treatment of these conditions in this population should be 
considered an indesirable health inequity.
Recommendations for research
We have well established that cardiovascular disease risk factors are a significant health 
issue among older people with intellectual disabilities. However, questions remain on 
explaining mechanisms and on the effect on cardiovascular morbidity and mortality. Is 
the observed cardiovascular risk profile merely a result of lifestyle and use of medication in 
this group, or are there fundamental differences between the aging group with intellectual 
disabilities and the general population, e.g. in the genetic predisposition or inherent to 
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the cause of the intellectual disability. Because of the cross-sectional character of the HA-
ID study, causality could not be studied. Moreover, more complex measurements should 
be performed, that may not all be feasible for use in large scale epidemiologic research 
among this vulnerable group of participants.
To unravel mechanisms, fundamental research should be combined with prospective 
outcome studies. Mechanisms from which the direction now is unclear, or where the 
magnitude of the effect in this population is yet unknown are those of inflammation, 
circadian rhythm, the endocrine cascade and the role of mood and stress of environmental 
factors.
In a representative population, baseline examinations should be performed in some detail, 
like in the HA-ID study. Not only people receiving formal care of an organization should 
be included, but also people with borderline intellectual disability who live independently 
in the community. Additionally, in targeted subgroups, inflammatory cytokines could 
be measured. Hormone function can be measured to differentiate between eating 
behavior effects (leptin and ghrelin) and insulin resistance effects (also mediated by 
inflammation). Day curves of melatonin levels from saliva can provide information on 
mechanisms behind circadian rhythm problems. Also from saliva, cortisol levels could 
provide information on the role of mood disorders and stress. To improve prediction of 
cardiovascular disease, newer risk markers such as amino-terminal pro-B-type natriuretic 
peptide (NT-Pro-BNP), high sensitive C-reactive protein and lipoprotein-associated 
phospholipase A2, but also non-invasive measurements of atherosclerosis such as carotid 
intima thickness, and coronary calcium score could be included [6, 139].
When in a longitudinal cohort study among adults and older people with ID, ideally for 
at least 10 years, not only these baseline measures are determined, but also well-defined 
and measured outcome data are gathered, more insight into the pathology that is specific 
for the population with intellectual disability would be created. Moreover, reliable 
epidemiological information on incidence of cardiovascular disease could emerge from 
such a design. This would lead to the possibility of designing more specific evidence 
based interventions, that are effective and that will result in significant health and quality 
of life improvement.
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Chapter 1 General introduction
There is an increasing group of older people with intellectual disability in The Netherlands, 
reaching almost the same life expectancy as the general population. Age-related diseases, 
such as cardiovascular disease, cancer and dementia are now the most encountered 
diseases and causes of death in older people with intellectual disabilities. Although 
cardiovascular disease is a major risk for older people with intellectual disabilities, no 
reliable information was available on cardiovascular disease risk factors, nor attention for 
prevention of cardiovascular disease was present prior to the start of the Healthy Ageing 
and Intellectual Disability (HA-ID) study. The HA-ID study aimed at gaining knowledge 
on healthy ageing by studying health and health risks in an older population of people with 
intellectual disabilities. Three large care organizations and two university departments 
participated in this study. Subthemes in the HA-ID study were: (1) Physical activity and 
fitness, (2) Nutrition and nutritional state, and (3) Mood and anxiety. By studying these 
themes and the interrelationships, a comprehensive concept of health and health-needs in 
aging people with intellectual disability would be created. Through physical examination, 
laboratory examination, and use of screening and diagnostic psychiatric interviews, data 
were collected on 1050 participants, aged 50 years and over with borderline to profound 
intellectual disability, which was a near-representative sample for the total older population 
using formal intellectual disability care. This study was performed to give more insight 
into the prevalence and associations of cardiovascular risk factors, and the subsequent 
development of atherosclerosis, in older people with intellectual disability in a large 
unbiased population sample.
Chapter 2 Overweight and obesity
As obesity is a major health problem associated with increased cardiovascular disease 
risks, the prevalence of overweight, obesity and body fat percentage in older people 
with intellectual disability through measurement of Body Mass Index (BMI), waist 
circumference, waist to hip ratio and skin fold thickness was studied and compared with 
prevalence of overweight and obesity in the general population. Associations of overweight 
and obesity with participant and treatment characteristics (gender, age, level of intellectual 
disability, Down syndrome, autism, independent living, smoking, (instrumental) activities 
of daily living, physical activity and use of atypical antipsychotic medication) were studied 
using regression analyses. Among 945 participants, overweight and obesity were highly 
prevalent, with more obesity (26%) than in the general Dutch older population (10%) as 
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measured by BMI, and 46-48% obesity as measured by waist circumference and waist to 
hip ratio respectively. Women, people with Down syndrome, higher age, less severe ID, 
autism, people who are able to eat independently, preparing meals and doing groceries 
independently, people with physical inactivity and use of atypical antipsychotics were 
significantly more at risk of being overweight or obese.
Chapter 3 Hypertension, hypercholesterolemia, diabetes and the meta-
bolic syndrome
Hypertension, hypercholesterolemia and diabetes are important cardiovascular disease 
risk factors. Together with abdominal obesity they form the metabolic syndrome, which 
indicates metabolic disturbances, consisting of insulin resistance and accounting for a 
severe risk of cardiovascular disease. We determined the prevalence of cardiovascular 
risk factors and compared this with the prevalence in the same-aged general population. 
Furthermore we determined how many risk factors had not been previously diagnosed, 
and identified correlates of CVD risk factors (gender, age, level of ID, Down syndrome, 
independent living, activities of daily living, mobility, instrumental activities of daily living, 
physical activity, use of atypical antipsychotics, central obesity), using logistic regression 
analyses. Ninehundred-eighty people participated in this study. Hypertension (53%), 
diabetes (14%) and metabolic syndrome (45%) were present similarly as in the general 
Dutch population. Hypercholesterolemia was present less often (23%). Fifty percent of 
the people with hypertension had not been not previously diagnosed with this condition. 
Percentages for diabetes, hypercholesterolemia, and the metabolic syndrome were 45, 
46 and 94 respectively. People who were more at risk for CVD risk factors were women, 
older people, people with obesity, people who lived more independently and people who 
were able to do groceries or prepare a meal independently.
Chapter 4 Peripheral arterial disease
Peripheral arterial disease, atherosclerosis distal from the aortic bifurcation, is associated 
with increased cardiovascular morbidity and mortality. We determined the prevalence of 
peripheral arterial disease, the rate of prior diagnoses, and correlations with participant 
characteristics, and compared the prevalence with peripheral arterial disease in the 
general Dutch population. Peripheral arterial disease was defined as an ankle-brachial 
index < 0.9. After excluding those, who met the exclusion criteria, 629 participants 
Summary_Channa.indd   115 9-7-2014   9:32:05
116
Summary
remained. Peripheral arterial disease was present in 20.7% of the participants and 97% 
had not been diagnosed before. People with higher age, smokers and people who lived 
in central settings, walked with support and who were more dependent in activities of 
daily living were more at risk of peripheral arterial disease. The prevalence is higher than 
in the general population (17.4% of 562 eligible participants with ID, as compared to 
8.1% of 917 Dutch participants of the PANDORA study, a pan-European study into the 
prevalence of peripheral arterial disease) through all age groups. 
Chapter 5 Association with anxiety and depression symptoms
Depression and anxiety may be bidirectionally related to cardiovascular disease risk 
factors. Depression and anxiety may have biological effects causing glucose intolerance, fat 
accumulation and also lifestyle changes causing metabolic syndrome. But also the effects 
of diabetes, metabolic syndrome and subsequent cardiovascular disease may affect mood 
and anxiety. We studied the association between symptoms of anxiety and depression, 
among 990 participants who completed the screening instruments, with components of 
the metabolic syndrome, peripheral arterial disease and c-reactive protein. Of the 990 
people who participated, 17% had symptoms of depression and 16% had symptoms of 
anxiety. In a multivariate logistic regression analysis a significant association was found 
between increased anxiety symptoms and diabetes only (OR 2.4, 95% CI 1.2-4.9).
Chapter 6 Chronic kidney disease
Prevalence and associations of chronic kidney disease were studied using creatinine 
and cystatin-C measurement in plasma. Glomerular filtration rate was calculated 
using the Modification of Diet in Renal Disease (MDRD) and Chronic Kidney Disease 
Epidemiology Collaboration (CKD-EPI) equations. Equations based on creatinine (as 
the MDRD equation) may underestimate kidney dysfunction in people with sarcopenia, 
because low muscle mass leads to a low creatinine production. Therefore, also prevalence 
of chronic kidney disease was studied in the sarcopenic group, using different glomerular 
filtration rate equations. Prevalence of chronic kidney disease, among 635 participants, 
was 15.3%, which equals prevalence in the general Dutch population. In the group of 
participants with sarcopenia (n = 82), the CKD-EPI equation based on creatinine and 
cystatin-C gave a higher prevalence of chronic kidney disease than did the MDRD 
equation, but confidence intervals were very wide. Chronic kidney disease was associated 
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with higher age, Down syndrome, obesity, hypercholesterolemia and hypothyroid 
disease. Glomerular filtration rate should be measured in all older people with ID and 
polypharmacy, and in older people with ID and Down syndrome as part of the regular 
health checks. Moreover, if sarcopenia is present and information on GFR is required, 
this should not be measured based on creatinine only, but additional measures, such as 
cystatin-C, should be taken into account.
Chapter 7 General discussion
Some important cardiovascular disease risk factors, which are also a burden of disease 
by themselves: peripheral arterial disease, diabetes and obesity (in women), occur more 
often among aging people with intellectual disability than in the same aged general 
population. Other risk factors, hypertension, metabolic syndrome, obesity in men and 
chronic kidney disease, occur as frequently as in the general population. People who 
live more independently are more at risk for cardiovascular disease risk factors, which 
reflects lifestyle related factors, such as physical inactivity and unhealthy diet choices. 
Other possible related factors in the intellectually disabled population (such as use of 
atypical antipsychotics, mood and anxiety disorders, circadian rhythm disturbances, low 
vitamin D, effects of inactivity of the large muscles, chronic inflammation and frailty) 
are discussed. This study has shown that everyone who works with or for older people 
with intellectual disabilities should be well aware of the cardiovascular disease risk. An 
anticipating preventive policy should be embedded in the whole care for people with 
intellectual disability. This includes education on healthy lifestyle for personal care givers 
and for people with mild levels of intellectual disability. Furthermore, care providing 
organizations should incorporate targeted health promotion programs in daily care and 
activities. General practitioners and specialized physicians for people with intellectual 
disabilities should perform pro-active cardiovascular risk management, starting before 
the client is aged 50 years. This includes screening for and treatment of cardiovascular 
risk factors, peripheral arterial disease and kidney dysfunction. Recommendations for 
future research are provided to improve knowledge and care on cardiovascular disease risk 
factors and subsequent cardiovascular disease for older people with intellectual disabilities.
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Hoofdstuk 1 Algemene Inleiding
Er is een toenemende verouderende groep mensen met een verstandelijke beperking in 
Nederland die inmiddels bijna dezelfde levensverwachting hebben als de algemene po-
pulatie. Verouderingsziekten, zoals cardiovasculaire ziekten, kanker en dementie zijn nu 
de meest voorkomende ziekten en doodsoorzaken onder mensen met een verstandelijke 
beperking. Hoewel het risico op hart- en vaatziekten groot is onder mensen met een ver-
standelijke beperking, bestond er geen betrouwbare informatie over het voorkomen van 
de risicofactoren en over preventie van hart- en vaatziekten, voor aanvang van de GOUD 
(Gezond ouder met een verstandelijke beperking) studie. De GOUD-studie was er op 
gericht om kennis over gezonde veroudering te verwerven, door de gezondheid en ge-
zondheidsrisico’s te bestuderen in een oudere populatie verstandelijk gehandicapten. Drie 
grote zorgorganisaties en twee universitaire afdelingen participeerden in het onderzoek. 
Subthema’s binnen het onderzoek waren: (1) Fysieke activiteit en fitheid, (2) Voeding en 
voedingstoestand en (3) Stemming en angst. Door deze thema’s en de onderlinge relaties 
te onderzoeken zou een totaalbeeld van de gezondheid en gezondheidsbehoeften van 
ouderen met een verstandelijke beperking worden gecreëerd. Met behulp van lichamelijk 
onderzoek, bloedonderzoek en het gebruik van screenende en diagnostische psychiatri-
sche interviews werden gegevens verzameld van 1050 deelnemers van 50 jaar en ouder 
met zwakbegaafdheid of een lichte tot zeer ernstige verstandelijke beperking. Dit was een 
bijna representatieve steekproef van de totale populatie ouderen met een verstandelijke 
beperking die gebruik maken van enige vorm van zorg of ondersteuning van een zorg-
aanbieder voor verstandelijk gehandicapten. Dit onderzoek werd uitgevoerd om meer 
inzicht te verwerven in de prevalentie en associaties van cardiovasculaire risicofactoren 
en de hierop volgende ontwikkeling van atherosclerose in een grote representatieve 
steekproef ouderen met een verstandelijke beperking.
Hoofdstuk 2 Overgewicht en obesitas
Obesitas is een ernstig gezondheidsprobleem, geassocieerd met een verhoogd risico op 
hart- en vaatziekten. Daarom werd de prevalentie van overgewicht en obesitas en het vet-
percentage in het lichaam onderzocht bij ouderen met een verstandelijke beperking door 
middel van meting van de Body Mass Index (BMI), middelomtrek, middelheupratio en 
huidplooidikte. Prevalenties werden vergeleken met die van de algemene oudere populatie. 
Middels regressie-analyses werden geassocieerde factoren bestudeerd (geslacht, leeftijd, 
mate van de verstandelijke beperking, Down syndroom, autisme, mate van zelfstandig 
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wonen, roken, (instrumentale) activiteiten van het dagelijks leven, fysieke activiteit, en 
gebruik van atypische antipsychotica). Onder de 945 deelnemers aan de huidige metingen 
waren overgewicht en obesitas een veel voorkomend probleem. Gemeten met de BMI was 
er meer obesitas (26%) dan in de algemene Nederlandse oudere bevolking (10%). Met de 
middelomtrek en middelheupratio hadden respectievelijk 46-48% obesitas. Risicogroepen 
voor obesitas waren vrouwen, mensen met Down syndroom, mensen op hogere leeftijd, 
met een minder ernstige mate van de verstandelijke beperking, autisme, mensen die in 
staat waren om zelfstandig te eten, maaltijden te bereiden en boodschappen te doen, 
mensen die weinig fysiek actief waren en mensen die atypische antipsychotica gebruikten.
Hoofdstuk 3 Hypertensie, hypercholesterolemie, diabetes en het meta-
bool syndroom
Hypertensie, hypercholesterolemie en diabetes zijn belangrijke cardiovasculaire risico-
factoren. Zij vormen samen met centrale obesitas het metabool syndroom, wat wijst op 
metabole ontregeling bestaande uit insulineresistentie, en wat een sterk verhoogd risico 
geeft op hart- en vaatziekten. In deze studie werden de prevalentie van deze cardiovascu-
laire risicofactoren bepaald en vergeleken met de prevalentie in de algemene populatie. 
Verder werd onderzocht hoeveel van deze risicofactoren nog niet eerder gediagnosti-
ceerd waren en wat de geassocieerde factoren van deze cardiovasculaire risicofactoren 
waren (geslacht, leeftijd, mate van verstandelijke beperking, Down syndroom, mate 
van zelfstandig wonen, (instrumentale) activiteiten van het dagelijks leven, mobiliteit, 
gebruik van atypische antipsychotica en centrale obesitas), met behulp van logistische 
regressie-analyses. Er namen 980 mensen deel aan de metingen. Hypertensie (53%), 
diabetes (14%) en het metabool syndroom (45%) kwamen even vaak voor als in de al-
gemene Nederlandse populatie. Hypercholesterolemie kwam minder vaak voor (23%). 
De helft van de mensen met hypertensie was hiermee niet eerder gediagnosticeerd. Voor 
diabetes, hypercholesterolemie en het metabool syndroom was dat respectievelijk 45, 46 
en 94 procent. Mensen die vaker cardiovasculaire rsicofactoren hadden waren vrouwen, 
mensen op hogere leeftijd, mensen met obesitas, mensen die zelfstandiger woonden en 
mensen die zelfstandig boodschappen konden doen of zelf een maaltijd konden bereiden.
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Hoofdstuk 4 Perifeer arterieel vaatlijden
Perifeer arterieel vaatlijden, atherosclerose distal van de aortabifurcatie, is geassocieerd 
met een verhoogd risico op morbiditeit en mortaliteit ten gevolge van hart- en vaat-
ziekten. De prevalentie van perifeer arterieel vaatlijden, het aantal diagnoses hiervan 
voorafgaande aan de studie en de geassocieerde factoren werden onderzocht. De preva-
lentie werd vergeleken met die in de algemene Nederlandse populatie. Perifeer arterieel 
vaatlijden was gedefinieerd als een enkel-armindex < 0.9. Na exclusie van mensen in 
een rolstoel bleven er 629 deelnemers over. Van hen voldeed 20.7% aan de criteria voor 
perifeer arterieel vaatlijden. 97% van de mensen met perifeer arterieel vaatlijden waren 
niet eerder met deze aandoening gediagnosticeerd. Risicogroepen waren mensen op ho-
gere leeftijd, mensen die rookten, mensen die op een centrale locatie woonden, mensen 
die liepen met een hulpmiddel en mensen die afhankelijker waren in hun vaardigheden 
betreffende de activiteiten van het dagelijks leven. De prevalentie was hoger dan in de 
algemene bevolking (17.4% van 562 vergelijkbare deelnemers, vergeleken met 8.1% van 
917 Nederlandse deelnemers aan de PANDORA studie, een pan-Europese studie naar 
de prevalentie van perifeer arterieel vaatlijden) in alle leeftijdscategorieën. 
Hoofdstuk 5 Associatie met symptomen van angst en depressie
Depressie en angst zijn bidirectioneel gerelateerd aan cardiovasculaire risicofactoren. 
Depressie en angst hebben mogelijk biologische effecten die glucose-intolerantie, vet-
ophoping en leefstijlveranderingen die tot het metabool syndroom leiden, mede ver-
oorzaken. Maar ook kunnen het metabool syndroom, diabetes en de hierop volgende 
hart- en vaatziekten de stemming en angst beïnvloeden. De relaties tussen symptomen 
van angst en depressie, onder de 990 deelnemers bij wie de screeningsinstrumenten waren 
afgenomen, en componenten van het metabool syndroom, perifeer arterieel vaatlijden 
en c-reactive protein werden bestudeerd. 17% van de deelnemers had symptomen van 
depressie en 16% had symptomen van angst. Met een logistische regressie-analyse werd 
alleen een significante associatie gevonden tussen aanwezigheid van symptomen van 
angst en het hebben van diabetes (OR 2.4, 95% CI 1.2-4.9).
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Hoofdstuk 6 Chronische nierziekte
De prevalentie en geassocieerde factoren van chronische nierziekte werden onderzocht 
door bepaling van kreatinine en cystatine-C in plasma. De glomerulaire filtratiesnelheid 
werd berekend met de “Modification of Diet in Renal Disease” (MDRD) formule en met 
de verschillende “Chronic Kidney Disease Epidemiology Collaboration” (CKD-EPI) 
formules. Formules gebaseerd op kreatinine (zoals de MDRD-formule) kunnen nierfunc-
tiestoornissen onderschatten bij mensen met sarcopenie, omdat de lage spiermassa leidt 
tot een lage kreatinineproductie. Daarom werd ook de prevalentie van nierfunctiestoornis-
sen onder de deelnemers met sarcopenie onderzocht, waarbij de verschillende formules 
vergeleken werden. De prevalentie van chronische nierziekte onder 635 deelnemers was 
15.3%. Chronische nierziekte kwam even vaak voor als in de algemene Nederlandse 
bevolking. Bij de 82 deelnemers met sarcopenie gaf de CKD-EPI-formule gebaseerd op 
kreatinine en cystatine-C een hogere prevalentie van chronische nierziekte dan de MDRD-
formule, maar de betrouwbaarheidsintervallen waren erg breed. Mensen met een hogere 
leeftijd, Down syndroom, obesitas, hypercholesterolemia en hypothyreoidie hadden een 
verhoogde kans op chronische nierfunctiestoornissen. De glomerulaire filtratiesnelheid 
zou bij alle ouderen met een verstandelijke beperking en polyfarmacie gemeten moeten 
worden en bij mensen met Down syndroom als onderdeel van de reguliere healthwatch. 
Als er sprake is van sarcopenie en de nierfunctie moet onderzocht worden, dan zou die 
niet alleen gebaseerd moeten worden op de glomerulaire filtratiesnelheid op basis van 
het kreatinine, maar zouden ook aanvullende bepalingen, zoals cystatine-C, gedaan 
moeten worden.
Hoofdstuk 7 Algemene discussie
Een aantal cardiovasculaire risicofactoren die zelf ook een ziektelast kunnen zijn, namelijk 
perifeer arterieel vaatlijden, diabetes en obesitas (bij vrouwen) komen vaker voor onder 
ouderen met een verstandelijke beperking dan in de algemene oudere Nederlandse be-
volking. Andere risicofactoren, hypertensie, metabool syndroom, obesitas bij mannen 
en chronische nierziekte komen even vaak voor als in de algemene bevolking. Mensen 
die zelfstandiger wonen hebben een hoger risico op cariovasculaire risicofactoren, wat 
veroorzaakt wordt door de leeftstijlgerelateerde factoren, zoals fysieke inactiviteit en 
ongezonde dieetkeuzes. Andere mogelijke gerelateerde factoren in de verstandelijk 
gehandicapte populatie (zoals het gebruik van atypische antipsychotica, stemmings- en 
angststoornissen, circadiane ritmestoornissen, een laag vitamine D-gehalte, effecten van 
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inactiviteit van de grote spieren, chronische inflammatie en geriatrische kwetsbaarheid) 
worden bediscussieerd. Deze studie heeft aangetoond dat iedereen die werkzaam is in de 
zorg voor of ondersteuning van mensen met een verstandelijke beperking, zich bewust 
moet zijn van de risico’s op hart- en vaatziekten. Er zou een anticiperend preventief beleid 
moeten worden ingebed in de totale zorg voor mensen met een verstandelijke beperking. 
Dit bestaat onder andere uit onderwijs over een gezonde leefstijl voor zorgverleners en 
mensen met een lichte verstandelijke beperking. Verder zouden zorgorganisaties doel-
gerichte gezondheidsbevorderende programma’s onderdeel moeten laten uitmaken van 
de dagelijkse zorg en activiteiten. Huisartsen en artsen voor verstandelijk gehandicapten 
zouden pro-actief cardiovasculair risicomanagement moeten aanbieden en uitvoeren, te 
beginnen voor de cliënt 50 jaar oud is. Dit omvat het screenen voor en behandelen van 
cardiovasculaire risicofactoren, perifeer arterieel vaatlijden en chronische nierziekte. Er 
worden aanbevelingen gedaan voor verder onderzoek om de kennis en zorg te verbeteren 
voor ouderen met een verstandelijke beperking en cardiovasculaire risicofactoren en 
daarop volgende ziekten.
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Moeder, dokter en onderzoeker tegelijk zijn, dat kan je nooit alleen. Op deze plaats wil 
ik alle mensen bedanken die het tot stand komen van dit proefschrift mede mogelijkheid 
hebben gemaakt, op welke manier dan ook.
Ten eerste wil ik de 1050 cliënten van de zorgorganisaties bedanken voor hun deelname 
aan het GOUD-onderzoek. Dapper en volhardend hebben zij deelgenomen aan de 
metingen, om ons meer te leren over hun gezondheid. Ook hun familie en begeleiders 
wil ik bedanken voor hun medewerking en inzet. Zonder al deze mensen zou het GOUD-
onderzoek nooit geworden zijn wat het nu is.
Natuurlijk bestaat er geen promotieonderzoek zonder promotor, prof. dr. Heleen Evenhuis. 
Heleen, je hebt me de kans geboden om dit avontuur aan te gaan. Jouw kwaliteiten, je visie 
en je doortastendheid hebben je gebracht waar je nu bent, hoogleraar, AVG en ontwerper 
van GOUD. Vanuit die positie heb je me geïnspireerd, opgeleid in de wetenschap en 
begeleid in dit proces. Maar ook hebben we samen uitgebreid gesproken over het pad dat 
ik volg, wat veel overeenkomsten vertoont met het pad dat jij zelf gevolgd hebt. Hartelijk 
dank voor je vertrouwen en ondersteuning.
Michael Echteld, mijn co-promotor, ik wil jou bedanken voor jouw vriendelijkheid, 
enthousiasme, kritische blik en de methodologische ondersteuning. Je was altijd bereid 
mee te denken en extra vragen te stellen.
Prof. dr. P.J.E. Bindels, prof. dr. H.M.J. van Schrojenstein Lantman-de Valk en prof. 
A.W. Hoes wil ik bedanken voor hun snelle beoordeling van het manuscript en hun 
bereidheid om deel te nemen aan de promotiecommissie. Prof. dr. O.H. Franco, prof. 
dr. E.J.G. Sijbrands en dr. J.J. Stolker wil ik bedanken voor hun bereidheid om deel te 
nemen in de grote commissie. Joost Jan, jou wil ik tevens bedanken voor je aanstekelijke 
enthousiasme en de manier waarop je mij hebt laten kennismaken met de intrigerende 
SGLVG-doelgroep bij Wier en het combineren van wetenschap en praktijk daarin. Ik 
hoop dat er nog veel casuïstiek zal volgen.
Het GOUD-onderzoek heeft enorm veel opgeleverd, misschien wel meer dan vooraf zou 
kunnen zijn bedacht. Van wetenschappelijke resultaten, tot invloed op maatschappelijke 
en politieke ontwikkelingen. GOUD-bestuurders, Nico Peelen en later Jan Duenck van 
Abrona, Ronald Herder van Amarant en Jan Fidder en later Jan van Hoek van Ipse de 
Bruggen, dat jullie dit voorzagen getuigt van visie. Tevens getuigt het van lef om in deze 
tijd te investeren en te bouwen aan zo’n grootschalig onderzoek. Voor beide wil ik jullie 
bedanken. Nico, jou wil ik tevens bedanken voor de samenwerking in de tijd dat ik 
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bij Abrona werkte. Ik heb jouw laagdrempelige en betrokken manier van besturen erg 
gewaardeerd. Ook de directeuren zorg en intern coördinatoren, Marcel Schellart, Frank 
Brouwer, Ineke Bootsman, Erwin van der Hout, Arjen Louisse, Anemone Linthorst en 
Joris van Erp, wil ik bedanken voor hun onmisbare bijdrage aan het mogelijk maken 
van dit enorme project.
Luc, Thessa, Heidi en Marieke, de eerste GOUD-onderzoekers. Wat hebben jullie een 
hoop werk verzet om iedereen te mobiliseren en alle cliënten te onderzoeken. Dankzij 
jullie enorme inzet zijn deze wereldwijd unieke data beschikbaar voor onderzoek en heb 
ik dit deelonderzoek kunnen uitvoeren.
Ook de andere onderzoekers van de vakgroep, Sandra, Josje S, Alyt, Marieke W, Sonja 
en Ellen wil ik bedanken voor de samenwerking, het wisselen van gedachten en de 
gezelligheid.
Frans Ewals en Mary Wolswinkel, dankjulliewel voor jullie vertrouwen in mij en dat jullie 
het voor mij mogelijk hebben gemaakt om dit onderzoek uit te voeren.
Een speciale plaats verdient Josje Thijssen, mijn AVG-opleider. Josje, jij hebt me 
geënthousiasmeerd, en ook de kneepjes van het vak geleerd. Tevens ben jij voor mij een 
ongeëvenaard voorbeeld in het multitasken.
Keimpe de Haan, ik had de luxe van twee opleiders, dus twee keer zoveel leren. Dankjewel 
dat je mij hebt willen laten leren van je AVG-kunsten!
Al mijn collega’s van Reinaerde, dat zijn er te veel om op te noemen, maar toch wil ik 
ieder van jullie bedanken voor de fijne samenwerking, jullie geduld met mij, jullie begrip 
als ik dingen voor mijn onderzoek moest doen, maar vooral voor onze gedeelde zorg 
voor de cliënten van Reinaerde.
Marlies en Karla dan toch in het bijzonder. Vriendinnen en collega’s, leuker kan toch niet? 
Ik blijf van jullie leren, niet alleen over de inhoud, maar ook over hoe we alle drie dingen 
met hetzelfde doel toch steeds verschillend aanpakken. En laten we in deze drukke tijden 
opletten dat, zodra het werk de overhand neemt, het tijd is voor een wijntje op de boot!
Mijn lieve vriendinnen, Florine, Noortje, Christine, Sara, Alice, Vera, Juna, Annemarijn, 
Wendelien, Linda, gezelligheid, afleiding en delen van frustraties, hoogte- en dieptepunten, 
het is allemaal nodig in ons aller drukke bestaan. Dankjulliewel voor dit alles.
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Charlotte en Caroline, dankjulliewel dat jullie mijn paranimfen willen zijn en mij bijstaan 
op deze bijzondere dag! Char, we kropen al samen rond, later werd het huppelen en 
uiteindelijk lieten we ons vooral heen en weer rijden door onze knollen. Door dik en dun! 
Caro, je bent altijd lief en betrokken, ook jij kent de promotieperikelen. Super lief dat je je 
reis naar Australië voor mij hebt willen uitstellen. Maar gaan zul je, dat heb je verdiend. 
Zolang je maar weer terug komt, zodat we nog veel plezier kunnen hebben samen!
Schoon-famiglia, con voi la vita e molto bella. Vi amo. Voi ricevete da me il “Nobel-price 
for being”.
En dan mijn fotomodellen natuurlijk. Want voor de duidelijkheid, de mensen op de 
omslag zijn de slimste mensen die ik ken. Mijn opa is er helaas niet meer bij. Hij was 
een voorbeeld voor iedere wetenschapper, als uitvinder van de pil, maar bovendien een 
van de meest sensitieve mensen die ik kende. En lieve oma wat ben ik blij dat jij er bent! 
Lief en zorgzaam, mijn kinderen hebben je niet voor niets omgedoopt tot oma TIEN!
Lieve Ilja, wat is het belangrijk om een broer te hebben. Om elkaar uit te dagen, plezier 
te hebben en te begrijpen. En dan heb ik nog wel zo’n lieve broer als jij! Wat een geluk 
heb ik toch!
De kinderen van de fietsenmaker hebben rammelende fietsen. En de kinderen van de 
schoenmaker lopen met gaten in hun schoenen. Dan moet het met de kinderen van een 
hoogleraar pedagogiek en een consultatiebureauarts wel heel rampzalig aflopen… Niet 
dus! Lieve pap en mam, waar zou ik zijn zonder jullie. Jullie zijn de liefste ouders die 
ik me kan wensen. Jullie hebben ons altijd gestimuleerd om te doen wat we kunnen en 
willen, altijd vanuit de warme thuisbasis. En nog steeds staan jullie altijd voor ons klaar. 
Nu ook als super-oma en partici-opa van onze schatjes. Jullie zijn geweldig!
Niek, mijn liefielief! Je vond me bij de Albert Heijn tussen de groente. Toen als studenten, 
nu als groot gezin. Wat onveranderd blijft is ons plezier samen, onze interesses en de 
liefde. En wat is er mooier dan dat delen met Luïsa, Jonah en Leander, onze drie mooiste 
en liefste kindertjes van de hele wereld?
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CurriCulum vitae
Channa Femke de Winter werd geboren op 30 augustus 1980 in Utrecht. Na het behalen 
van haar VWO diploma aan de Werkplaats Kindergemeenschap in Bilthoven in 1998 
begon zij aan haar studie geneeskunde in Utrecht. Tijdens haar studie deed ze onderzoek 
naar hormonale effecten op het cognitief functioneren bij de afdeling endocrinologie. 
In 2005 behaalde zij haar artsexamen. Daarna werkte ze als arts-assistent psychiatrie bij 
Altrecht, afdeling Wier, waar zij naast haar klinische werkzaamheden wetenschappelijk 
onderzoek deed naar psychiatrische problematiek bij verstandelijk gehandicapten. In 
2006 startte zij met de opleiding tot arts voor verstandelijk gehandicapten (AVG) aan 
het Erasmus MC, met als werkplekken achtereenvolgens zorgaanbieders Bartiméus en 
Abrona. Ze werkte in deze periode in opdracht van het CCE aan het onderzoek naar 
somatische oorzaken van probleemgedrag. In 2009 rondde zij de opleiding tot AVG af 
en werkte vervolgens als AVG bij Bartiméus en Wier. Sinds februari 2011 is zij werkzaam 
als AVG en bopz-arts binnen Reinaerde en in maart 2011 startte zij daarnaast met haar 
promotieonderzoek binnen de Leerstoel Geneeskunde voor Verstandelijk Gehandicapten 
aan het Erasmus MC te Rotterdam, waarvan het huidige proefschrift het resultaat is. Sinds 
2012 is zij tevens opleider binnen Reinaerde voor artsen in opleiding tot AVG.
Channa woont samen met Niek Verwey en zij zijn trotse ouders van Luïsa (2008), Jonah 
(2010) en Leander (2013).
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